ABAM Transitional Maintenance of Certification

Transitional Maintenance of Certification (tMOC) is a fundamental part of addiction medicine certification for current ABAM Diplomates. For more information or questions about the ABAM tMOC program, visit ABAM's website.

All of the courses below have been approved by the American Board of Addiction Medicine for tMOC.

ABAM tMOC Approved Courses

  • The ASAM Alcohol Withdrawal Management Guideline Webinar Series

    Contains 5 Product(s)

    This 5-part webinar series discusses the ASAM Alcohol Withdrawal Management Guideline. Areas of focus include (1) the fundamentals of the guideline, (2) identification, diagnosis, and initial assessment, (3) monitoring, levels of care, and inpatient/ambulatory treatment, (4) pharmacotherapy, as well as (5) complicated withdrawal and special populations.

    image

    The ASAM Alcohol Withdrawal Management Guideline Webinar Series


    Alcohol is responsible for a multitude of health conditions, including Alcohol Withdrawal Syndrome (AWS). While frequently presented in specialty addiction treatment settings, patients experiencing or at risk for developing AWS also receive care in hospitals, emergency departments, and primary care settings. The current management of patients with AWS is inconsistent across care settings and evidence-based care is often not provided. The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management was developed to address current practice concerns and provide clear guidance that will lead to more consistent treatment practices in the field. The series is primarily intended for clinicians who provide alcohol withdrawal management in specialty and non-specialty addiction treatment settings. 

    All webinars in the series will be free for ASAM members to join live and watch the recorded on-demand session. For non-ASAM members, it will be free to join live and watch on-demand webinars for 90-days after the live webinar date. Following the 90 days, non-ASAM members can purchase the on-demand webinars for $39 each or at a discounted price for the entire 5-webinar package. The first webinar focused on the Fundamentals will continue to be free for everyone. 

    Webinar Series Topics & Dates

    1. Fundamentals: Wednesday, July 29, 2020; 1:00 pm ET
    2. Identification, Diagnosis & Initial Assessment: Monday, August 24, 2020; 1:00 pm ET 
    3. Monitoring, Levels of Care & Inpatient/Ambulatory Treatment: Tuesday, September 15, 2020; 1:00 pm ET
    4. Pharmacotherapy: Tuesday, October 20, 2020; 12:00 pm ET
    5. Complicated Withdrawal and Special Populations: Tuesday, November 17, 2020; 12:00 pm ET
    ACCME Accredited with Commendation

    CME/CE Credits

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this internet live course for a maximum of 5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification (MOC)

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 5 LLSA credit towards ABPM MOC Part II requirements.

    ABA Maintenance of Certification (MOC)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    ABP Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 5 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

    ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    ABAM Transitional Maintenance of Certification (Tmoc)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    Program Planning Committee, CME Committee, Medical Education Council (MEC)

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity. 

    ASAM CME Committee Reviewer

    Ed Salsitz, MD, DFASAM - No Financial Disclosures

    Faculty & Planning Committee Disclosures

    Lewis S. Nelson, MD, FASAM (Chair) – No Relevant Financial Disclosures

    Kurt Kleinschmidt, MD, FASAM – No Relevant Financial Disclosures

    Gerald E. Marti, MD, PhD – No Relevant Financial Disclosures

    Darius Rastegar, MD, FASAM – No Relevant Financial Disclosures

    Dazhe Cao, MD – No Relevant Financial Disclosures

    George Kolodner, MD, DLFAPA, FASAM – Does Disclose: Kolmac Outpatient Recovery Centers, Self, Employment, Ownership Interest (includes stock, stock options, patent or other intellectual property) Clinical Condition: Substance Use Disorder

    Michael F. Weaver, MD, DFASAM – No Relevant Financial Disclosures


    • Register
      • Non-Member - Free!
      • Regular Member - Free!
      • Retired - Free!
      • Early Career Physician - Free!
      • Resident - Free!
      • Student - Free!
      • Associate - Free!
      • ASAM Staff - Free!
      • International Member - Free!
      • Emeritus Member - Free!
      • Provisional Member - Free!
      • Fellow Member - Free!
      • Honorary Member - Free!
      • CRT Member - Free!
    • More Information
  • The ASAM National Practice Guideline 2020 Focused Update Webinar Series

    Contains 5 Product(s)

    This 5-part webinar series discusses the ASAM National Practice Guideline 2020 Focused Update. Topics include the fundamentals of the guideline update, and topics specific to pregnant women, opioid use disorder and pain, individuals in the Criminal Justice System, and adolescents and young adults.

    image

    The ASAM National Practice Guideline 2020 Focused Update Webinar Series


    Opioid use disorder is a chronic, relapsing disease, which has significant economic, personal, and public health consequences. The ASAM National Practice Guideline for the Use of Medications in the Treatment of Addiction Involving Opioid Use was developed to assist in the evaluation and treatment of opioid use disorder. Topics covered included: opioid withdrawal management, psychosocial treatment, special populations, and opioid overdose. The ASAM Guideline was the first guideline to address all medications available in the U.S. for the treatment of opioid addiction and overdose, in a single document. Since its publication in 2015, new medications and science in the field emerged, compelling ASAM to conduct a focused update.

    This 5-part webinar series discusses the ASAM National Practice Guideline 2020 Focused Update. Topics include the fundamentals of the guideline update, and topics specific to pregnant women, opioid use disorder and pain, individuals in the Criminal Justice System, and adolescents and young adults. This webinar series is primarily intended for clinicians involved in evaluating patients and providing authorization for pharmacological treatments at any level. 

    All webinars in the series will be free for ASAM members to join live and watch the recorded on-demand session. For non-ASAM members, it will be free to join live and watch on-demand webinars for 30-days after the live webinar date. Following the 30 days, non-ASAM members can purchase the on-demand webinars for $39 each or at a discounted price for the entire 5-webinar package. The first webinar focused on the Fundamentals will continue to be free for everyone. 

    Webinar Series Topics & Dates

    1. Fundamentals: Tuesday, May 26, 2020; 12:00 pm ET
    2. Pregnant Women: Tuesday, June 30, 2020; 2:00 pm ET
    3. OUD and Pain: Tuesday, July 21, 2020; 1:00 pm ET
    4. Individuals in the Criminal Justice System: Thursday, September 10, 2020; 12:00 pm ET
    5. Adolescents and Young Adults: Tuesday, September 24, 2020; 1:00 pm ET

    ACCME Accredited with Commendation

    CME/CE Credits

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this live internet-based activity for a maximum of 5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification (MOC)

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 5 LLSA credit towards ABPM MOC Part II requirements.

    ABA Maintenance of Certification (MOC)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    ABP Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 5 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

     ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    ABAM Transitional Maintenance of Certification (Tmoc)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    Program Planning Committee, CME Committee, Medical Education Council (MEC)

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity. 

    ASAM CME Committee Reviewer

    Subhadeep Barman, MD, FASAM, FAPA - No Financial Disclosures

    Faculty & Planning Committee Disclosures

    Kyle M. Kampman, MD – Does Disclose: World Meds (Clinical Condition: Opioid Use Disorder): Consultant/Advisory Board 

    Marc Fishman, MD – Does Disclose: Alkermes (Clinical Condition: OUD): Consultant/Advisory Board, Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received

    Tricia Wright, MD, MS, DFASAM – Does Disclose McKesson (Clinical Condition: Opioid use in pregnancy): Consultant/Advisory Board

    Sandra Springer, MD – Does Disclose: Alkermes Inc (Clinical Condition: Substance Use Disorder) Consultant/Advisory/Board, reviewed research grants for young investigators Clinical Care Options INc (Clinical Condition: Infectious disease) Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)

    George Woody, MD – Does Disclose: Alkermes Inc (Clinical Condition: Opioid Use Disorder) Consultant/Advisory/Board, Consultant/Advisory Board, Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) Indivior (Clinical Condition: opioid use disorders) Consultant/Advisory Board, Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) World Meds (Clinical Condition: Opioid Use Disorders) Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support)

    Daniel Langleben, MD – Does Disclose: Alkermes Inc (Clinical Condition: Opioid Use Disorder) Consultant/Advisory Board 

    Stephen A. Wyatt, DO, FAOAAM, FASAM (Chair) – No Financial Disclosure

    Timothy Wiegand, MD, FACMT, FAACT, DFASAM – No financial Disclosures


    • Register
      • Non-Member - Free!
      • Regular Member - Free!
      • Retired - Free!
      • Early Career Physician - Free!
      • Resident - Free!
      • Student - Free!
      • Associate - Free!
      • ASAM Staff - Free!
      • International Member - Free!
      • Emeritus Member - Free!
      • Provisional Member - Free!
      • Fellow Member - Free!
      • Honorary Member - Free!
      • CRT Member - Free!
    • More Information
  • The ASAM National Practice Guideline 2020 Focused Update Webinar – Adolescents & Young Adults

    Contains 4 Component(s), Includes Credits

    This session will provide an overview of the new and updated recommendations and in-depth information on treating youth with OUD from the ASAM National Practice Guideline.

    image

    The ASAM National Practice Guideline 2020 Focused Update Webinar – Adolescents & Young Adults


    This webinar follows the ASAM National Practice Guideline 2020 Focused Update Fundamentals webinar, which outlines the new and updated recommendations in the 2020 Focused Update of the National Practice Guideline for the Treatment of Opioid Use Disorder

    Adolescents and young adults present for treatment with a broad spectrum of opioid use disorder severity with a range of co-occurring medical and psychiatric illnesses. The treatment of youth with opioid use disorder presents many unique medical, legal, and ethical dilemmas that may complicate treatment. Given these unique issues, adolescents and young adults often benefit from services designed specifically for them. This webinar will provide an overview of the new and updated recommendations and in-depth information on treating youth with OUD from the ASAM National Practice Guideline.

    Session Information 

    Date: Thursday, September 24, 2020

    Time: 1:00 pm ET / 12:00 pm CT/ 10:00 am PT

    Speaker(s): Marc Fishman, MD

    Learning Objectives 

    By completing this webinar, you will be able to:

    1. Summarize the guideline’s treatment recommendations for adolescents and young adults with OUD and discuss how they should be used in practice. 
    2. Identify the fundamental components of an OUD patient assessment and diagnosis for adolescents and young adults.
    3. Recognize the unique needs and treatment recommendations for adolescents and young adults

    Marc Fishman

    MD

    Marc Fishman MD is a specialist in  addiction psychiatry and addiction medicine.  He is a member of the faculty of the Department of Psychiatry at the Johns Hopkins University School of Medicine. He leads Maryland Treatment Centers, which offers programs for residential and outpatient treatment of drug-involved and dual-diagnosis adolescents and adults. He has written and lectured widely on a variety of topics including youth treatment, placement and treatment matching strategies, co-occurring disorders, and medication treatment for addiction. His research focus has been in treatment of opioid use disorders in youth. Dr. Fishman served as a co-editor for the most recent editions of ASAMs Patient Placement Criteria, leading the adolescent section, and served as the chief editor for the ASAM PPC Supplement on Pharmacotherapies for Alcohol Use Disorders. He is the chair of the Adolescent Committee for ASAM. He is a Past President of the Maryland Society of Addiction Medicine, and a current memeber of its Board.

    ACCME Accredited with Commendation

    CME/CE Credits

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this live internet-based activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification (MOC)

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1 LLSA credit towards ABPM MOC Part II requirements.

    ABA Maintenance of Certification (MOC)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    ABP Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 1 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

     ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    ABAM Transitional Maintenance of Certification (Tmoc)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    Program Planning Committee, CME Committee, Medical Education Council (MEC)

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity. 

    ASAM CME Committee Reviewer

    Subhadeep Barman, MD, FASAM, FAPA - No Financial Disclosures

    Faculty & Planning Committee Disclosures

    Kyle M. Kampman, MD – Does Disclose: World Meds (Clinical Condition: Opioid Use Disorder): Consultant/Advisory Board 

    Marc Fishman, MD – Does Disclose: Alkermes (Clinical Condition: OUD): Consultant/Advisory Board, Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received

    Tricia Wright, MD, MS, DFASAM – Does Disclose McKesson (Clinical Condition: Opioid use in pregnancy): Consultant/Advisory Board

    Sandra Springer, MD – Does Disclose: Alkermes Inc (Clinical Condition: Substance Use Disorder) Consultant/Advisory/Board, reviewed research grants for young investigators Clinical Care Options INc (Clinical Condition: Infectious disease) Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)

    George Woody, MD – Does Disclose: Alkermes Inc (Clinical Condition: Opioid Use Disorder) Consultant/Advisory/Board, Consultant/Advisory Board, Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) Indivior (Clinical Condition: opioid use disorders) Consultant/Advisory Board, Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) World Meds (Clinical Condition: Opioid Use Disorders) Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support)

    Daniel Langleben, MD – Does Disclose: Alkermes Inc (Clinical Condition: Opioid Use Disorder) Consultant/Advisory Board 

    Stephen A. Wyatt, DO, FAOAAM, FASAM (Chair) – No Financial Disclosure

    Timothy Wiegand, MD, FACMT, FAACT, DFASAM – No financial Disclosures


    • Register
      • Non-Member - Free!
      • Regular Member - Free!
      • Retired - Free!
      • Early Career Physician - Free!
      • Resident - Free!
      • Student - Free!
      • Associate - Free!
      • ASAM Staff - Free!
      • International Member - Free!
      • Emeritus Member - Free!
      • Provisional Member - Free!
      • Fellow Member - Free!
      • Honorary Member - Free!
      • CRT Member - Free!
    • More Information
  • The ASAM Alcohol Withdrawal Management Webinar Series – Monitoring, Levels of Care, & Inpatient/Ambulatory Treatment

    Contains 4 Component(s), Includes Credits

    The third of its series, this webinar will provide an overview of the The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management's recommendations for monitoring patients with AWS in varying settings and levels of care.

    image


    The ASAM Alcohol Withdrawal Management Webinar Series – Monitoring, Levels of Care, & Inpatient/Ambulatory Treatment 


    The webinar follows the ASAM Alcohol Withdrawal Management Fundamentals webinar, which intends to aid clinicians in their clinical decision making and management of patients experiencing alcohol withdrawal syndrome, as written in The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management.

    Level of care determinations should be based on an evaluation of the expected risks and benefits of treatment within each setting and monitoring a patient with AWS should include multiple indicators of withdrawal progress and patient health. Given that alcohol withdrawal management services are provided in both inpatient and ambulatory settings, this webinar will provide an overview of the recommendations for monitoring patients with AWS in these varying settings and levels of care. 

    Session Information

    Date: Tuesday, September 15, 2020

    Time: 1:00 pm ET / 12:00 pm CT/ 10:00 am PT

    Speaker(s): George Kolodner, MD, DLFAPA, FASAM

    Learning Objectives

    By completing this session, you will be able to:

    • 1. Understand how to make an appropriate level of care determination for patients seeking alcohol withdrawal management services. 
    • 2. Identify the level of care determination tools available to help determine the appropriate level of care for patients with AWS.
    • 3. Summarize the guideline’s treatment recommendations around inpatient and ambulatory settings and recognize the difference in the services provided in each setting. 

    George Kolodner

    MD, DLFAPA, FASAM

    George Kolodner, MD, FASAM is the Medical Director of the Kolmac Clinic, a Clinical Professor of Psychiatry at both the Georgetown And University Schools of Medicine, and the current president of MDSAM, the Maryland State Chapter of ASAM. His specialty interests are the treatment of addictions in an outpatient setting and the treatment of co-occurring disorders.

    ACCME Accredited with Commendation

    CME/CE Credits

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring live course for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification (MOC)

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1 LLSA credit towards ABPM MOC Part II requirements.

    ABA Maintenance of Certification (MOC)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    ABP Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 1 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

    ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    ABAM Transitional Maintenance of Certification (Tmoc)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    Program Planning Committee, CME Committee, Medical Education Council (MEC)

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity. 

    ASAM CME Committee Reviewer

    Ed Salsitz, MD, DFASAM - No Financial Disclosures

    Faculty & Planning Committee Disclosures

    Lewis S. Nelson, MD, FASAM (Chair) – No Relevant Financial Disclosures

    Kurt Kleinschmidt, MD, FASAM – No Relevant Financial Disclosures

    Gerald E. Marti, MD, PhD – No Relevant Financial Disclosures

    Darius Rastegar, MD, FASAM – No Relevant Financial Disclosures

    Dazhe Cao, MD – No Relevant Financial Disclosures

    George Kolodner, MD, DLFAPA, FASAM – Does Disclose: Kolmac Outpatient Recovery Centers, Self, Employment, Ownership Interest (includes stock, stock options, patent or other intellectual property) Clinical Condition: Substance Use Disorder

    Michael F. Weaver, MD, DFASAM – No Relevant Financial Disclosures


    • Register
      • Non-Member - Free!
      • Regular Member - Free!
      • Retired - Free!
      • Early Career Physician - Free!
      • Resident - Free!
      • Student - Free!
      • Associate - Free!
      • ASAM Staff - Free!
      • International Member - Free!
      • Emeritus Member - Free!
      • Provisional Member - Free!
      • Fellow Member - Free!
      • Honorary Member - Free!
      • CRT Member - Free!
    • More Information
  • The ASAM National Practice Guideline 2020 Focused Update Webinar – Individuals in the Criminal Justice System

    Contains 4 Component(s), Includes Credits

    This session will provide an overview of the new and updated recommendations and in-depth information on treating individuals in the criminal justice system from the ASAM National Practice Guideline.

    image

    The ASAM National Practice Guideline 2020 Focused Update Webinar – Individuals in the Criminal Justice System


    This webinar follows the ASAM National Practice Guideline 2020 Focused Update Fundamentals webinar, which outlines the new and updated recommendations in the 2020 Focused Update of the National Practice Guideline for the Treatment of Opioid Use Disorder

    A substantial proportion of persons in prisons, jails, drug courts, probation, parole, and who are criminally involved have opioid use disorder and related problems. The high concentration of at-risk individuals and conditions of incarceration can increase the risk of adverse consequences associated with drug use, including violence, medical and psychiatric co-morbidity, drug-related deaths, self-harm and suicide. Furthermore, treatment of OUD in CJ settings has all too often been sub-standard. For example, when individuals are released from incarceration without OUD treatment, they are at extreme risk of relapse overdose and death. This webinar will provide an overview of the new and updated recommendations and in-depth information on treating individuals in the criminal justice system from the ASAM National Practice Guideline.

    Session Information 

    Date: Thursday, September 10, 2020

    Time: 12:00 pm ET / 11:00 am CT/ 9:00 am PT

    Speaker(s): Sandra Springer, MD

    Learning Objectives 

    By completing this webinar, you will be able to:

    1. Summarize the guideline’s treatment recommendations for individuals in the criminal justice system with OUD and discuss how they should be used in practice.
    2. Identify the fundamental components of an OUD patient assessment and diagnosis for individuals in the criminal justice system.
    3. Recognize the unique needs and treatment recommendations for individuals in the criminal justice system

    Sandra Springer

    MD

    Sandra Springer, MD is an Associate Professor of Medicine in the Department of Internal Medicine, Section of Infectious Diseases at the Yale School of Medicine. Dr. Springer is Board-Certified in Internal Medicine, Infectious Diseases and Addiction Medicine. In addition, she is the Director of the Infectious Disease Clinic at the Newington site of the VA Connecticut Healthcare System where she oversees the care of Veterans living with HIV (VLH). She graduated from Harvard University, then later received her Medical Degree from University of Massachusetts Medical School. She did her Internal Medicine Residency and Infectious Disease Fellowship at Yale School of Medicine. Dr. Springer has significant clinical and research experience with persons living with HIV disease (PLH) and those with comorbid substance use disorders (SUD). Her research has focused on evaluation of integration of SUD and HIV treatments. In particular, she has focused on medication treatment for opioid use disorder (OUD) (MOUD) and medication treatment for alcohol use disorders (AUD) to improve substance use relapse outcomes and HIV treatment outcomes, especially among those released from prison and jail. Dr. Springer has been continuously NIH funded for over 15 years. She has a K02 Independent Scientist Award from NIDA evaluating medication treatment for OUD (MOUD) interventions among PLH. Dr. Springer has been a buprenorphine provider since 2005, and performed the first evaluation of the use of buprenorphine to prevent relapse to opioid use and improve HIV viral suppression among PLH released from prison. She created and later validated a rapid opioid dependency screen (RODS) that quickly identifies if someone has a moderate to severe opioid use disorder (OUD) to quickly initiate MOUD. She has studied extended-release naltrexone (XR-NTX) as a PI on a 5 year NIAAA-funded R01 which used a RCT design to evaluate its effect on improving HIV viral suppression for PLH released from prison; and she was a PI on a NIDA-funded R01 within the Seek Test Treat and Retain (STTR) Criminal Justice System (CJS) consortium to evaluate the use of XR-NTX to improve HIV VS among PLH with OUD released from prison/jail.  Dr. Springer was a working group member of the NIDA STTR consortium that harmonized outcomes across 23 NIDA-funded STTR studies involving PLH and those who are at risk for HIV. Additionally, she was co-I on 2 NIDA R01s (1) using Buprenorphine to improve HIV treatment outcomes among CJS-involved PLH with OUD in Washington, D.C.; and (2) implementing XR-NTX among PLH with OUD in Ukraine. She is currently co-PI on a 5-year R01 from NIDA evaluating the impact of HIV infection on immunologic, transcriptomic, and metabolomic signatures among PLH compared to those without HIV infection who are beginning MAT for OUD. She is a co-PI with Drs. Ho and Kluger at Yale for a NIDA funded R33/R61 that is specifically evaluating the impact of all forms of MAT on HIV persistence; and she is a co-I on a HEALing NIDA funded grant to combat Opioid addiction in NY State. She is also the contact PI of a new U01 from NCATS that will integrate ID and injectable buprenorphine in hospitalized patients. She also is a co-PI on a new Justice involved HEALing grant at the NYU site with Dr. Josh Lee from NIDA evaluating OUD medication treatment for criminal justice involved persons with OUD and co-PI with Dr. Ismene Petrakis for a VA COOP grant among 900 Veterans with OUD comparing injectable and sublingual buprenorphine. She is a member of IDSA and HIVMA’s expert panel to integrate ID and OUD, a NASEM committee member evaluating the integration of ID and OUD treatment and prevention in community settings nationally, and a member of the ASAM committee that provided updated recommendations for use of MOUD in 2020. 

    ACCME Accredited with Commendation

    CME/CE Credits

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this live internet-based activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification (MOC)

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1 LLSA credit towards ABPM MOC Part II requirements.

    ABA Maintenance of Certification (MOC)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    ABP Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 1 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

     ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    ABAM Transitional Maintenance of Certification (Tmoc)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    Program Planning Committee, CME Committee, Medical Education Council (MEC)

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity. 

    ASAM CME Committee Reviewer

    Subhadeep Barman, MD, FASAM, FAPA - No Financial Disclosures

    Faculty & Planning Committee Disclosures

    Kyle M. Kampman, MD – Does Disclose: World Meds (Clinical Condition: Opioid Use Disorder): Consultant/Advisory Board 

    Marc Fishman, MD – Does Disclose: Alkermes (Clinical Condition: OUD): Consultant/Advisory Board, Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received

    Tricia Wright, MD, MS, DFASAM – Does Disclose McKesson (Clinical Condition: Opioid use in pregnancy): Consultant/Advisory Board

    Sandra Springer, MD – Does Disclose: Alkermes Inc (Clinical Condition: Substance Use Disorder) Consultant/Advisory/Board, reviewed research grants for young investigators Clinical Care Options INc (Clinical Condition: Infectious disease) Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)

    George Woody, MD – Does Disclose: Alkermes Inc (Clinical Condition: Opioid Use Disorder) Consultant/Advisory/Board, Consultant/Advisory Board, Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) Indivior (Clinical Condition: opioid use disorders) Consultant/Advisory Board, Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) World Meds (Clinical Condition: Opioid Use Disorders) Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support)

    Daniel Langleben, MD – Does Disclose: Alkermes Inc (Clinical Condition: Opioid Use Disorder) Consultant/Advisory Board 

    Stephen A. Wyatt, DO, FAOAAM, FASAM (Chair) – No Financial Disclosure

    Timothy Wiegand, MD, FACMT, FAACT, DFASAM – No financial Disclosures


    • Register
      • Non-Member - Free!
      • Regular Member - Free!
      • Retired - Free!
      • Early Career Physician - Free!
      • Resident - Free!
      • Student - Free!
      • Associate - Free!
      • ASAM Staff - Free!
      • International Member - Free!
      • Emeritus Member - Free!
      • Provisional Member - Free!
      • Fellow Member - Free!
      • Honorary Member - Free!
      • CRT Member - Free!
    • More Information
  • Pain Management and Opioids: Balancing Risks and Benefits - Illinois Society of Addiction Medicine - Saturday, September 12, 2020

    Contains 5 Component(s), Includes Credits

    Earn 3 AMA PRA Category 1™ Credits while learning about the latest science, clinical guidelines, and policies around pain and opioids and getting the tools you need to provide evidence-based pain treatment. Earn an additional 1 AMA PRA Category 1™ Credit while learning about sexual harassment in the medical field.

    image

    & Sexual Harassment in the Medical World

    Host: Illinois Society of Addiction Medicine

    Date: Saturday, September 12| 8:00 am – 12:00 pm CT

    Register for the live webinar here

    Cost: Free

    The misuse of opioids is a major public health problem. Centers for Disease Control and Prevention reported the following:

    • From 1999 to 2016 more than 630,000 people died from drug overdoses.
    • 115 Americans die every day from an opioid overdose.

    The CO*RE/ASAM Pain Management and Opioids: Balancing Risks and Benefits curriculum is newly updated to reflect the latest information in this vital area of healthcare. The thoroughly revised curriculum addresses: the nature and pathophysiology of pain; assessing patients in pain; creating a pain treatment plan; initiating opioid therapy; managing patients on opioid analgesics; educating patients and caregivers; and understanding opioid use disorder. This program meets many states requirements for opioid education and is fully compliant with the Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) education requirement (“Blue Print”), issued by the U.S. Food & Drug Administration in September 2018. 

    This product is worth a total of 4 AMA PRA Category 1™ Credits, 3 credits for the Paim Management and Opioids course and 1 credit for the Sexual Harassment in the Medical World course.

    Saturday, September 12, 2020 | 8:00 am – 12:00 pm CT

    Illinois Society of Addiction Medicine

    AGENDA:

    8:00 am – 8:15 amIntro
    8:15 am – 8:25 amChapter 1: Pain
    8:25 am – 8:35 amChapter 2: Terminology
    8:35 am – 8:55 amChapter 3:Assessment
    8:55 am –9:15 amChapter 4:Creating the Pain Treatment Plan
    9:15 am – 9:35 amBreak
    9:35 am – 9:55 amChapter 5: Managing Patients on Opioid Analgesics
    9:55 am – 10:15 amChapter 6:Educating Your Patients & Their Caregivers
    10:15 am – 10:30 amChapter 7: Understanding Opioid Use Disorder (OUD)
    10:30 am – 10:45 amQuestions
    10:45- 11:00 amBreak
    11:00 – 12:00 pmSexual Harassment in the Medical World

    John A. Peterson, MD, FASAM

    Medical Director of Chronic Pain Management, Danville, Illinois Veterans Administration Hospital

    Dr. John Peterson is Board Certified in both Internal Medicine and Addiction Medicine. 

    He staffed a large methadone clinic in Downers Grove, Illinois for ten years. 

    As an early adopter of buprenorphine medication assisted therapy, he has treated over eight hundred opioid disorder patients through his clinic in Champaign, Illinois.   

    He is Medical Director of Chronic Pain Management at the Danville, Illinois Veterans Administration Hospital. 

    He is a past president of the Illinois Society of Addiction Medicine.

    Sean O'Mahony, MD, BCh, BAO

    Associate Professor, Rush University Medical Center

    Dr. Sean O'Mahony is a palliative medicine physician and acts as the Director for the Section of Palliative and Supportive Medicine at Rush University Medical Center. Dr. O'Mahony's clinical interests include end-of-life care, chronic pain management and the palliation of the sequelae of chronic illnesses. His principal clinical and research goal is to reduce health care disparities for underserved communities. O'Mahony has directed multidisciplinary palliative medicine teams in academic medical centers that include social workers, chaplains, advanced practice nurses and physicians for 15 years. 

    O'Mahony's fellowship at Memorial Sloan Kettering Cancer Center included one year devoted to clinical research. I investigated the association between cancer pain and desire for hastened death. His research and teaching interests include pain management, end-of-life and palliative care, quality-of-life at the end-of-life and clinical outcomes and effectiveness of palliative care programs, and how to meet the needs of the underserved and minority communities at the end of life. He has implemented multidisciplinary research demonstration projects in palliative medicine in the Emergency Department, Intensive Care Unit, and Video-conference projects between long-term care and acute care settings and am co-demonstrating a three year multi-center multidisciplinary Chicago land educational demonstration program to expand access to palliative care in community settings across the metropolitan area. Dr. O'Mahony's current research activities include evaluation of the effectiveness of multi-institutional education programs, use of medical informatics to promote patient safety in relationship to use of opioid medications and integration of palliative medicine into the care of patients in the intensive care unit. He served on the Diversity and Inclusion Taskforce for the American Academy of Hospice and Palliative Medicine (AAHPM) and he established and chaired the Lesbian, Gay, Bisexual and Transgender Special Interest Group in the AAHPM. Dr. O'Mahony is the current co-chaired of the Diversity and Inclusion Committee for AAHPM.  

    Brian Harris, MD

    Dr. Brian Harris is a board-certified anesthesiologist trained atthe University of California at San Diego. His teaching experience includes four years as an adjunct clinicalinstructor for the University of North Dakota instructing medical students and residents.He served as the director of medical education for the Department of Anesthesiaat Sanford Medical Center and staffed the Acute Pain Service treating acute andacute-on-chronic perisurgical pain. He teaches a course in ABA Oral Boardcertification, and administers mock oral board examinations to prospectivediplomates. He attended the Feinberg School of Medicine at NorthwesternUniversity and lives in Chicago with his wife, son, and cat.

    Lindsay Harms, MS, LCPC, LSOE, LSOTP

    Licensed Clinical Professional Counselor

    Lindsay Harms, MS, LCPC, LSOE, LSOTP has experience working with clients since 2002 in school, residential, agency, home, and private practice settings.  She earned a master’s degree in Clinical and Community Mental Health from Western Illinois University.  She has extensive experience working with children, adolescents, adults, and families in a wide variety of settings dealing with anxiety, depression, divorce, gender and sexuality, life changes, sexual abuse victimization/perpetration, and various other issues.

    Credits and Disclosures


    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this internet live course for a maximum of 3 AMA PRA Category 1 Credits™ for the Pain Management and Opioids: Balancing Risks and Benefits course and 1AMA PRA Category 1 Credits™ for the Sexual Harassment in the Medical World course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification


    American Board of Preventive Medicine (ABPM)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 4 LLSA credits towards ABPM MOC Part II requirements.

    American Board of Anesthesiology (ABA)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    American Board of Pediatrics (ABP)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 4 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

    American Board of Internal Medicine (ABIM)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credits.

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    American Board of Addiction Medicine (ABAM)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    CME Reviewer and Disclosure Information


    ASAM CME Committee Reviewer

    Catherine Friedman, MD, FAPA, DFASAM – No Relevant Financial Disclosures 

    Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    Faculty and Panelists


    Raymond Bertino, MD – No Relevant Financial Disclosures 
    Peoria, IL

    John A. Peterson, MD, FASAM – No Relevant Financial Disclosures 
    Medical Director, Recovery Options of Champaign County, Champaign, IL

    Sean O'Mahony, MD, BCh, BAO – No Relevant Financial Disclosures 
    Associate Professor, Rush University Medical Center, Chicago, IL

    Brian Harris, MD– No Relevant Financial Disclosures 
    Chicago, IL

    Lindsay Harms, MS, LCPC, LSOE, LSOTP – No Relevant Financial Disclosures
    Peoria, IL

    • Register
      • Non-Member - Free!
      • Regular Member - Free!
      • Retired - Free!
      • Early Career Physician - Free!
      • Resident - Free!
      • Student - Free!
      • Associate - Free!
      • ASAM Staff - Free!
      • International Member - Free!
      • Emeritus Member - Free!
      • Provisional Member - Free!
      • Fellow Member - Free!
      • Honorary Member - Free!
      • CRT Member - Free!
    • More Information
  • The ASAM Alcohol Withdrawal Management Webinar Series - Identification, Diagnosis, and Initial Assessment

    Contains 4 Component(s), Includes Credits

    The second of its series, this webinar will provide an overview of the The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management's assessment recommendations around alcohol withdrawal management and in-depth information on tools and differential diagnosis.

    image


    The ASAM Alcohol Withdrawal Management Webinar Series – Identification, Diagnosis, and Initial Assessment 


    The webinar follows the ASAM Alcohol Withdrawal Management Fundamentals webinar, which intends to aid clinicians in their clinical decision making and management of patients experiencing alcohol withdrawal syndrome, as written in The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management.

    Signs and symptoms of AWS can escalate quickly and the trajectory of alcohol withdrawal can vary considerably among patients. As the most severe presentations of alcohol withdrawal are life threatening, orienting the initial assessment toward evaluating risk is recommended. The second of its series, this webinar will provide an overview of the assessment recommendations around alcohol withdrawal management and in-depth information on tools and differential diagnosis. 

    Session Information

    Date: Monday, August 24, 2020

    Time: 1:00 pm ET / 12:00 pm CT/ 10:00 am PT

    Speaker(s): Kurt Kleinschmidt, MD and Dazhe Cao, MD

    Learning Objectives

    By completing this session, you will be able to:

    • 1. Summarize the guideline’s treatment recommendations around assessment of alcohol withdrawal syndrome and discuss how they should be used in practice. 
    • 2. Recognize the risk assessment tools available to identify patients at risk of developing alcohol withdrawal.
    • 3. Describe how to make appropriate differential diagnosis.

    Kurt Kleinschmidt

    MD

    Kurt C. Kleinschmidt, MD, FACMT, FASAM is a Professor of Emergency Medicine at the University of Texas Southwestern Medical Center in Dallas, Texas.  He is Chief of the Division of Medical Toxicology.  His areas of interest include Substance Use Disorders and snake envenomations. He graduated from the University of South Florida College of Medicine in 1986, completed his emergency medicine residency at Madigan Army Medical Center in 1990, and finished a clinical fellowship in Medical Toxicology at the University of Texas Southwestern Medical Center in 1999.  He is board certified in Emergency Medicine (1991), Medical Toxicology (2002), and Addiction Medicine (2015). He became the Medical Director of the Perinatal Intervention Program in Parkland Health and Hospital system in 2016. He served as the Toxicology Program Director from 2004-2018.

    Dazhe (James) Cao

    MD

    Dazhe (James) Cao, MD s an Assistant Professor in the Department of Emergency Medicine at UT Southwestern Medical Center. 

    Dr. Cao earned his medical degree at Baylor College of Medicine. He completed a residency in emergency medicine at Carolinas Medical Center and received advanced training in medical toxicology through a fellowship at Rocky Mountain Poison & Drug Safety. 

    Certified by the American Board of Emergency Medicine in emergency medicine and medical toxicology, he joined the UT Southwestern faculty in 2015. 

    Dr. Cao is Program Director of Medical Toxicology at UT Southwestern and Medical Director of Toxicology for the Parkland Health & Hospital System. He serves on the American College of Medical Toxicology’s Fellowship Directors committee. 

    In addition, he is a member of the American Academy of Clinical Toxicology, the American College of Emergency Physicians, and the Emergency Medicine Residents’ Association.

    Dr. Cao has delivered numerous national and regional invited lectures, contributed to the seventh edition of the book Emergency Medicine Secrets, and published several academic articles.

    ACCME Accredited with Commendation

    CME/CE Credits

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this internet live course for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification (MOC)

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1 LLSA credit towards ABPM MOC Part II requirements.

    ABA Maintenance of Certification (MOC)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    ABP Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 1 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

    ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    ABAM Transitional Maintenance of Certification (Tmoc)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    Program Planning Committee, CME Committee, Medical Education Council (MEC)

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity. 

    ASAM CME Committee Reviewer

    Ed Salsitz, MD, DFASAM - No Financial Disclosures

    Faculty & Planning Committee Disclosures

    Lewis S. Nelson, MD, FASAM (Chair) – No Relevant Financial Disclosures

    Kurt Kleinschmidt, MD, FASAM – No Relevant Financial Disclosures

    Gerald E. Marti, MD, PhD – No Relevant Financial Disclosures

    Darius Rastegar, MD, FASAM – No Relevant Financial Disclosures

    Dazhe Cao, MD – No Relevant Financial Disclosures

    George Kolodner, MD, DLFAPA, FASAM – Does Disclose: Kolmac Outpatient Recovery Centers, Self, Employment, Ownership Interest (includes stock, stock options, patent or other intellectual property) Clinical Condition: Substance Use Disorder

    Michael F. Weaver, MD, DFASAM – No Relevant Financial Disclosures

    • Register
      • Non-Member - Free!
      • Regular Member - Free!
      • Retired - Free!
      • Early Career Physician - Free!
      • Resident - Free!
      • Student - Free!
      • Associate - Free!
      • ASAM Staff - Free!
      • International Member - Free!
      • Emeritus Member - Free!
      • Provisional Member - Free!
      • Fellow Member - Free!
      • Honorary Member - Free!
      • CRT Member - Free!
    • More Information
  • Treatment of Opioid Use Disorder: Waiver Qualifying - Baltimore, MD - Saturday, September 26, 2020

    Contains 6 Component(s), Includes Credits

    The ASAM Treatment of Opioid Use Disorder Course covers all medications and treatments for opioid use disorder, and provides the required education needed to obtain the waiver to prescribe buprenorphine.

    image

    Host: Johns Hopkins University

    Date: Saturday, September 26, 2020 | 8:30 am - 12:30 pm ET

    Live Virtual Course

    Online Portion Due: Friday, September 25, 2020

    Register for the webinar here: https://us02web.zoom.us/webinar/register/WN_gUHMBbSmR8iubqi_PL5gsA

    Overview 

    Welcome to The ASAM Treatment of Opioid Use Disorder Course online access. This course covers all medications and treatments for opioid use disorder, and provides the required education needed to obtain the waiver to prescribe buprenorphine. ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training.
    This is an 8-hour blended course combining 4 hours of online learning followed by 4 hours of live learning. The live portion of the course builds off content delivered in the online portion. Course faculty are expecting learners to complete the online portion before attending the live portion. You must complete both portions to receive credit for the course. 

    Getting Started 

    To begin the online portion of the course, please log-in to your left and locate the box that says "View Course." If you do not know your password, or you have forgotten it, select "Forgot Password" and you will be emailed a link to reset your password. If you have any questions, please contact education@ASAM.org.

    Learning Objectives

    Module 1 

    1. Assess patients for the full spectrum of harmful opioid use including misuse and use disorders
    2. Describe the current epidemiologic trends in opioid misuse including overdose and use disorders
    3. Recall opioid use neurobiology as it applies to the development of an opioid use disorder and relapse risk
    4. Summarize the laws regulating office-based opioid treatment including the Drug Addiction Treatment Act of 2000 and the Comprehensive Addiction and Recovery Act of 2016
    5. Summarize the clinical pharmacology, efficacy and safety of methadone, buprenorphine and naltrexone in treating opioid use disorders

    Module 2

    1. Identify and assess patients who are appropriate for treatment with medications for an opioid use disorder in an office-based setting
    2. Describe procedures for setting up office systems to support medication prescribing for opioid use disorders
    3. Describe procedures for initiating, stabilizing, maintaining, monitoring and modifying treatment of patients on buprenorphine or naltrexone

    Module 3

    1. Summarize the assessment and management of patients with psychiatric and medical co-morbidities associated with opioid use disorders
    2. Describe unique issues of treating adolescents, young adults, pregnant and postpartum patients maintained on medications for opioid use disorders
    3. Summarize acute and chronic pain management strategies for patients with an opioid use disorder

    Overall

    Apply for a waiver to prescribe buprenorphine to patients with opioid use disorder

    Target Audience

    1. Physicians, Nurse Practitioners, Physician Assistants, Certified Nurse Midwives, Certified Registered Nurse Anesthetists, and Clinical Nurse Specialists who wish to obtain a waiver to prescribe buprenorphine in an office-based setting for opioid use disorder.
    2. Clinicians and healthcare team members working with physicians who prescribe buprenorphine in office-based treatment of opioid use disorder.
    ACCME Accredited with Commendation

    CME/CE Credits

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring activity for a maximum of 4 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    The American Society of Addiction Medicine designates this live internet-based activity for a maximum of 4 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification (MOC)

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 8 LLSA credit towards ABPM MOC Part II requirements.

    ABA Maintenance of Certification (MOC)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    ABP Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 8 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

     ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    ABAM Transitional Maintenance of Certification (Tmoc)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    ASAM Treatment of Opioid Use Disorder Course Program Planning Committee

    NameNature of Relevant Financial Relationship
    Dan Alford, MD, MPH, DFASAM, ChairNone
    Edwin Salsitz, MD, DFASAM, Curriculum DirectorNone
    Alta DeRoo, MD, FASAM, FACOGNone
    Soraya Azari, MDNone
    Jill Mattingly, DHSc, MMSc, PA-CNone
    Debra Newman, PA-C, MPAS, MPHCommercial Interest: AbbVie
    What was received: Honoraria
    Role: Expert faculty for CME activities
    Commercial Interest: Gilead
    What was received: Honoraria
    Role: Expert faculty for CME activities
    Mary McMasters, MD, DFASAMNone
    Yngvild K. Olsen, MD, MPH, DFASAMNone
    Shawn Ryan, MD, MBA, FASAMCommercial Interest: Crosswave 
    What was received: Stock 
    Role: Advisor
    Commercial Interest: Dynamicare
    What was received: Stock
    Role: Advisor
    Kristin Smith, DNP, FNP-C, AAHIVSNone
    Tricia E. Wright, MD, MS, FACOG, DFASAMNone

    ASAM CME Committee

    NameNature of Relevant Financial Relationship
    Catherine Friedman, MD, FAPA, DFASAM, ChairNone
    Catharina Armstrong, MD, MPHNone
    Subhadeep Barman, MD, FASAM, FAPANone
    Benjamin Bearnot, MD, MPH, FASAMCommercial Interest: Johnson and Johnson
    What was received: Common stock
    Role: None
    Commercial Interest: Baxter International
    What was received: Common stock
    Role: None
    Commercial Interest: Takeda Pharmaceuticals
    What was received: Common stock
    Role: none
    R. Jeffrey Goldsmith, MD, DLFAPA, DFASAMCommercial Interest: Alkermes
    What was received: Travel expenses
    Role: Speaker
    Zwaantje H. Hamming, FNP-C, CARN-APNone
    Herbert L. Malinoff, MD, FACP, DFASAM None
    Noel Ilogu, MD, MRCP, DFASAMNone
    Edwin A. Salsitz, MD, DFASAMNone
     ASAM Staff and Consultants
    Arlene C. Deverman, MA, CAE, CFRENone
    Sandy MetcalfeNone
    Kate M. BrundageNone

    ASAM Medical Education Council

    NameNature of Relevant Financial Relationship
    Peter Selby, MBBS, CCFP, FCFP, MHSc, DFASAM, ChairCommercial Interest: Johnson & Johnson; Novartis; Pfizer Inc.
    What was received: Received free/discounted materials for research studies through an open tender process
    Role: Research Studies
    Commercial Interest: Pfizer Inc. Global Research Awards for Nicotine Dependence (GRAND).
    What was received: Grant funds
    Role: Principal investigator on research study
    Commercial Interest: Johnson & Johnson E-NRT Advisory Board
    What was received: Consulting Fees
    Role: Consulting on Johnson & Johnson E-NRT Advisory Board
    Daniel P. Alford, MD, MPH, DFASAMNone
    Michael Fingerhood, MD, FACP, FASAMNone
    Catherine R. Friedman, MD, FAPA, DFASAMNone
    Adam J. Gordon, MD, MPH, FACP, DFASAMNone
    Miriam S. Komaromy, MD, FACP, DFASAMNone
    Edwin A. Salsitz, MD, DFASAMNone
    Brian Hurley, MD, MBA, DFASAMNone
    Mark A. Weiner, MD, FASAMNone
     ASAM Staff and ConsultantsNone
    Penny S. Mills, MBANone
    Arlene C. Deverman, MA, CAE, CFRENone
    Marcia Jackson, PhDNone
    Dawn C. PiotrowskiNone
    Molly S. MazukNone
    Alexandra (Alli) KrouseNone
    Jennifer L. SilverCommercial Interest: Merck
    What was received: Spouse received stocks
    Role: Stockholder


    How to Apply for a Waiver

    Physicians

    SAMHSA reviews waiver applications within 45 business days of receipt. If approved, you will receive a letter via email that confirms your waiver and includes your prescribing identification number.

    Waiver applications are forwarded to the DEA. DEA regulations require your prescribing identification number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with your regular DEA number.

    If you have not received confirmation of receipt of your application, or if it has been more than 45 business days since submitting it, contact CSAT by email: infobuprenorphine@samhsa.hhs.gov or call 866.287.2728.

    Other Approved Prescribers

    Apply

    NPs and PAs who have completed the 24 hours of required training may seek to obtain a DATA 2000 waiver for up to 30 patients by completing the Waiver Notification Form. Effective February 27, 2017, SAMHSA will only accept electronic submissions of the NOI.

    NPs and PAs may send copies of their training certificates to csatbupinfo@dsgonline.com. These waiver applications are forwarded to the Drug Enforcement Administration (DEA), which will assign the NP or PA a special identification number. DEA regulations require this number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with the NP’s or PA’s regular DEA registration number.

    SAMHSA shall review waiver applications within 45 days of receipt. If approved, NPs and PAs will receive a letter via email that confirms their waiver and includes their prescribing identification number. 

    Qualify

    To qualify for a waiver to treat patients with Opioid Use Disorder, NPs and PAs must:

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain
    • Complete no less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD
    • If required by state law, supervision or working in collaboration with a qualifying physician to prescribe medications for the treatment of OUD may be required.

    Please ensure that your state regulations allow you to prescribe buprenorphine and other medications to treat OUD before you apply for the waiver.  Some states may have overriding state legislation that will prevent NPs from prescribing these medications even if Federal law allows it.

    Overview of Legislation

    Physicians

    The Drug Abuse Treatment Act of 2000 (DATA 2000) specifies training is necessary for physicians to obtain a waiver to engage in office‐based treatment of opioid use disorders using drugs approved by the FDA on Schedules III, IV, and V. This course addresses those requirements using a curriculum approved by CSAT/SAMHSA and ASAM, who is one of the national organizations named in the DATA 2000 legislation as eligible to prepare and administer these courses.

    Nurse Practitioners & Physician Assistants

    On July 22, 2016, President Obama signed the Comprehensive Addiction and Recovery Act (CARA) into law. CARA authorizes qualified NPs and PAs to become waivered to prescribe buprenorphine in office-based settings for patients with Opioid Use Disorder (OUD) for a five-year period expiring in October 2021.    

    To qualify, NPs and PAs must: 

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain  
    • Complete not less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD  
    • If required by state law, be supervised or work in collaboration with a qualifying physician to prescribe medications for the treatment of OUD

    HHS' announcement on November 16, 2016, enables NPs and PAs to immediately begin taking the 24 hours of required training. For the full HHS announcement, click here.

    NPs and PAs can begin the training immediately by taking the 8-hour buprenorphine course ASAM currently offers or that other stakeholders offer (see below for more information). The remaining 16 hours will have to be completed with one training provider. ASAM is developing multiple 16-hour training course options and formats, including collaborations with:

    The ASAM Treatment of Opioid Use Disorder Course has been made available in part by an unrestricted educational grant from Indivior Inc.

    • Register
      • Non-Member - Free!
      • Regular Member - Free!
      • Retired - Free!
      • Early Career Physician - Free!
      • Resident - Free!
      • Student - Free!
      • Associate - Free!
      • ASAM Staff - Free!
      • International Member - Free!
      • Emeritus Member - Free!
      • Provisional Member - Free!
      • Fellow Member - Free!
      • Honorary Member - Free!
      • CRT Member - Free!
    • More Information
  • ASAM Criteria Course: Friday, September 18, 2020

    Contains 4 Component(s), Includes Credits

    The ASAM Criteria Course is a practical workshop designed to help counselors, social workers, administrators, and other clinical staff develop patient-centered service plans and make objective decisions about patient admission, continuing care, and transfer/discharge for individuals with addictive, substance-related, and co-occurring conditions.

    image

            image


    Friday, September 18, 2020
    8:30 am - 5:30 pm ET

    Overview

    The ASAM Criteria Course will comprise of a comprehensive suite of competency-based learning activities in a distance learning delivery method and the live webinar delivery format that meets the learning needs of the multiple audiences making use of the Criteria and results in the appropriate use of the Criteria in practice. This is a practical training designed to help beginner, intermediate, and advanced counselors, social workers, administrators, and other clinical staff develop patient-centered service plans and make objective decisions about patient admission, continuing care, and transfer/discharge for individuals with addictive, substance-related, and co-occurring conditions. The workshop content is based on information found in The ASAM Criteria: Treatment Criteria for Addictive, Substance-Related, and Co-Occurring Conditions, Third Edition and incorporates an opportunity for participants to practice applying the information through case-based activities.

    The ASAM Criteria Course can also serve as a bridge to the implementation of a provider credentialing program. Providers who have completed ASAM approved training on The ASAM Criteria can gain the initial skill set to deliver care in compliance with The ASAM Criteria.

    Learning Objectives

    1. Describe the underlying principles and concepts of the ASAM Criteria.
    2. Identify the six dimensions of the ASAM Criteria’s multidimensional patient assessment.
    3. Determine treatment priorities based on risk assessment to guide treatment and service planning.
    4. Determine an appropriate level of care and treatment priorities based on risk assessment.
    5. Implement the ASAM Criteria, in the context of system challenges, for patients with addiction to ensure appropriate level of care and treatment outcomes.

    Christine R. Mulford

    RN, MSN, FNP-BC

    Christine brings her more than 15 years of clinical and leadership experience as a Nurse Practitioner to the practice of addiction medicine. She is passionate about individualized patient care as well as community education to end the stigma of substance use and mental health issues.

    Together with her physician partner, she started the first Emergency Room based
    withdrawal management service in the greater Phoenix area. Additionally, she maintains a private addiction medicine practice in Scottsdale, Arizona. Christine received her Master’s Degree in Nursing from Vanderbilt University where she was the 1998 Julia Hereford Merit Scholar. She resides in Phoenix, Arizona with her 2 sometimes well-behaved dogs. She enjoys live music, sports, and trying new hot sauces.

    Jennifer Harrison,

    PhD, LMSW, CAADC

    Jennifer r is a social worker, chemical addictions counselor, and an associate professor and the interim director for the School of Social Work at Western Michigan University.  Jennifer’s clinical work focuses on integrated substance use, mental health, and physical health services for individuals with co-occurring needs.  Her research interests and publication record include international social justice, co-occurring mental health, substance abuse, and medical needs among adults, implementation of evidence-based practices, and peer services in behavioral health.  

    Jennifer co-authored the book Tips and topics:  Opening the toolbox for transforming services and systems with David Mee-Lee.  She has presented on interprofessional research and teaching in the U.S and internationally, and served on multiple expert panels with SAMHSA.  Jennifer is a co-principal investigator in two HRSA funded projects to impact the interprofessional behavioral health workforce.  She has co-developed a digital application, Goal Scaling Solutions, for use in telehealth and education settings, to help people develop, monitor, and communicate about their goals for wellness and recovery.

    Credits and Disclosures


    ACCME Accreditation Statement:

    The American Society of Addiction Medicine (ASAM) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. 

    The American Society of Addiction Medicine designates this enduring activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

    In accordance with the disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all educational activities. These policies include resolving all conflicts of interest between the CME Committee, Planning Committee and faculty, and commercial interests that might otherwise compromise the goal and educational integrity of this activity. All CME Committee, Planning Committee and faculty participating in the activity have disclosed all relevant financial relationships with commercial interests. The CME Committee has reviewed these disclosures and determined that the planning committee and faculty relationships are not inappropriate in the content of their respective presentations and are not inconsistent with the educational goals and integrity of the activity. 

    ASWB Accreditation Statement:

    Social Workers: ASAM has applied for consideration of CE credits through ASWB ACE.

    NAADAC: 

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming. 

    California Association for Drug/Alcohol Educators (CAADE)


    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Programs (CADTP)


    This educational program is approved by CADTP, Provider #205

    ASAM CME Committee

    Name Commercial Interest Compensation Role
    Catherine R. Friedman, MD, DFASAM None NA NA
    Noel Ilogu, MD, MRCP, FASAM None NA NA
    Herbert Malinoff, MD, FACP, DFASAM None NA NA
    Edwin A. Salsitz, MD, DFASAM None NA NA
    R. Jeffrey Goldsmith, MD, DLFAPA, DFASAM None NA NA
    Adam J. Gordon, MD, MPH, FACP, DFASAM None NA NA
    Zwaantje Hamming, FNP-C, CARN-AP None NA NA

    Program Planning Committee

    Name Commercial Interest Compensation Role
    Corey Waller, MD, MS, DFASAM, FACEP, Chair None NA NA
    David Mee-Lee, MD, FASAM None NA NA
    David R. Gastfriend, MD, DFASAM
    None NA NA
    Lewis Breitner, PhD, LADC, LMFT
    None NA NA
    Amy Davis, DO, MS, FACP, FAAHPM
    None NA NA
    Jennifer Harrison, PhD, LMSW, CAADC
    None NA NA
    Melissa Holland, MA, MD, FACOG, CAADC
    None NA NA
    Christine Mulford, RN, MSN, FNP-BC
    None NA NA
    Surita Rao, MBBS, FASAM
    None NA NA
    Gerald D. Shulman, MA, MAC, FACATA
    None NA NA

    ASAM Criteria Education Committee Consultants

    Name Commercial Interest Compensation Role
    David Mee-Lee, MD, FASAM 1. Change Companies
    2. Train for Change
    1. Royalties
    2. Training fees
    1. Developing and delivering eTraining modules and Interactive Journals on ASAM Criteria
    2. Training workshops on ASAM Criteria
    David R. Gastfriend, MD, DFASAM 1. ASAM
    2. Alkermes
    3. Intent Solutions
    4. DynamiCare Health BiorCorRx, FEi Systems, Horizon BCBS, IBM Watson
    1. Royalty
    2. Stockholder
    3. Stock
    4. Stock, salary
    5. Fee
    1. Chief Architect (Agent) CONTINUUM
    2. Stockholder
    3. Consultant
    4. Chief Medical Officer & Co-Founder
    5. Consultant

    Faculty

    Name Commercial Interest Compensation Role
    David Mee-Lee, MD, FASAM 1. Change Companies
    2. Train for Change
    1. Royalties
    2. Training fees
    1. Developing and delivering eTraining modules and Interactive Journals on ASAM Criteria
    2. Training workshops on ASAM Criteria

    ASAM CME Committee Reviewers

    Name Commercial Interest Compensation Role
    Adam Gordon, MD, MPH, FACP, CMRO, DFASAM None NA NA
    Herbert Malinoff, MD, FACP, DFASAM None NA NA

    How to Claim Credits


    To claim continuing education (CE) and/or continuing medical education (CME) credit, follow the steps below.

    STEP 1

    Complete all the content modules in the course located under "Course Content (5)." Each module contains instructional materials, interactive exercises, and knowledge checks. After completing the five modules, take the end of the course assessment.

    STEP 2

    Complete the post-course evaluation. Fill out the survey by clicking the blue "Fill out Survey" button. Be sure to scroll down on all Likert Scale questions. There are answers that expand past the size of the survey window. Submit the evaluation (the next box should activate, and the evaluation box should turn green with a white check mark).

    STEP 3

    Click the button “Claim Credits” in the box titled "Download Course Certificate." Choose the type of credit (Physician or Non-physician) and click submit. Click the button “View/Print Certificate” to save or print your certificate. If you ever lose your certificate, you can come back to the ASAM e-Learning Center and view it on your transcript (found in the Dashboard).

    Fees


    ASAM Member, Retired, Early Career Physician: $149.00

    ASAM Member, Retired, Early Career Physician: $149.00

    ASAM Resident, Student, Associate Members: $99.00

    All refund requests and cancellations must be made in writing and emailed to ASAM's Education Department: education@asam.org

    If you require ADA Accommodations, please contact ASAM's Education Department.

    All questions and concerns must be made in writing and emailed to ASAM's Education Department: education@asam.org

    System Requirements


    Please ensure that the location of where you plan to access the live stream program meets hardware, software and bandwidth requirements well in advance. 

    It is recommended that you use a PC or MAC with an updated Internet Browser. Internet Explorer is NOT recommended
    • Ensure that pop-ups blockers are disabled in your Internet browser settings.
    • Audio (sound) is projected through your computer speakers. Be sure your computer is equipped with speakers or the room where the conference is being broadcast is equipped with speakers so you can hear the presenters.

    Browser Tests: Please take the following browser test. Please review the following Technical Requirements and be sure your system and networks are up-to-date. 

    https://support.zoom.us/hc/en-us/articles/115002262083-Joining-a-test-meeting

    Minimum System Requirements: 2.0Ghz Processor or faster 2 GB RAM (Greater than 2 GB recommended)

    Minimum Browser Requirements: Browser must support HTML-5. To detect your browser version, run https://whichbrowser.net/ 

    • Windows 7 or later 
    • Mac OS X 10.9 or later 
    • Chrome 60 or greater 
    • Firefox 52 or greater 
    • Edge 14 or greater 
    • Safari 10 or greater 
    • iOS 10 or greater 

    Internet Explorer is NOT recommended 

    IP Addresses and Ports to Allow for HTML5: 

    • 72.32.161.112 port 80, 443 (web and audio) 
    • 72.32.200.104 port 80, 443 (web and audio) 
    • 72.32.221.65 ports 80, 443 (web and audio)
    • 72.32.221.66 ports 80, 443 (web and audio)
    • 67.203.7.114 ports 80, 443 (web and audio)
    • Register
      • Non-Member - $199
      • Regular Member - $149
      • Retired - $149
      • Early Career Physician - $149
      • Resident - $99
      • Student - $99
      • Associate - $99
      • ASAM Staff - Free!
      • International Member - $149
      • Emeritus Member - $149
      • Provisional Member - $149
      • Fellow Member - $149
      • Honorary Member - $149
      • CRT Member - $149
    • More Information
  • Pain Management and Opioids: Balancing Risks and Benefits - Illinois Society of Addiction Medicine - Saturday, August 8, 2020

    Contains 5 Component(s), Includes Credits

    Earn 3 AMA PRA Category 1™ Credits while learning about the latest science, clinical guidelines, and policies around pain and opioids and getting the tools you need to provide evidence-based pain treatment. Earn an additional 1 AMA PRA Category 1™ Credit while learning about sexual harassment in the medical field.

    image

    & Sexual Harassment in the Medical World

    Host: Illinois Society of Addiction Medicine

    Date: Saturday, August 8| 8:00 am – 12:00 pm CT

    Register for the live webinar here

    Cost: Free

    The misuse of opioids is a major public health problem. Centers for Disease Control and Prevention reported the following:

    • From 1999 to 2016 more than 630,000 people died from drug overdoses.
    • 115 Americans die every day from an opioid overdose.

    The CO*RE/ASAM Pain Management and Opioids: Balancing Risks and Benefits curriculum is newly updated to reflect the latest information in this vital area of healthcare. The thoroughly revised curriculum addresses: the nature and pathophysiology of pain; assessing patients in pain; creating a pain treatment plan; initiating opioid therapy; managing patients on opioid analgesics; educating patients and caregivers; and understanding opioid use disorder. This program meets many states requirements for opioid education and is fully compliant with the Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) education requirement (“Blue Print”), issued by the U.S. Food & Drug Administration in September 2018. 

    This product is worth a total of 4 AMA PRA Category 1™ Credits, 3 credits for the Paim Management and Opioids course and 1 credit for the Sexual Harassment in the Medical World course.

    Saturday, August 8, 2020 | 8:00 am – 12:00 pm CT

    Illinois Society of Addiction Medicine

    AGENDA:

    8:00 am – 8:15 amIntro
    8:15 am – 8:25 amChapter 1: Pain
    8:25 am – 8:35 amChapter 2: Terminology
    8:35 am – 8:55 amChapter 3:Assessment
    8:55 am –9:15 amChapter 4:Creating the Pain Treatment Plan
    9:15 am – 9:35 amBreak
    9:35 am – 9:55 amChapter 5: Managing Patients on Opioid Analgesics
    9:55 am – 10:15 amChapter 6:Educating Your Patients & Their Caregivers
    10:15 am – 10:30 amChapter 7: Understanding Opioid Use Disorder (OUD)
    10:30 am – 10:45 amQuestions
    10:45- 11:00 amBreak
    11:00 – 12:00 pmSexual Harassment in the Medical World

    Gagandeep Goyal

    MD

    Dr. Goyal is triple board certified, anesthesiologist, pediatric anesthesiologist, and addictionologist. Dr. Goyal is trained at Drexel University, Philadelphia and University of Pittsburgh Medical Center, Pittsburgh, PA. Dr. Goyal is currently CEO/President of www.awsillinois.com, A tele-health company based in Loves Park, IL. Dr. Goyal's practice is 70 % anesthesiology and 30 % addiction medicine. Dr. Goyal likes biking and running and loves to spend time with his wife Dr. Shami Goyal and his 2 kids.

    Patrick Leonberger

    DO

    Dr. Patrick Leonberger, DO is from St. Louis, MO. He graduated from Truman State University with a BS in Psychology and Kirksville College of Osteopathic Medicine. He completed an internal medicine residency at Banner University Medical Center in Phoenix, AZ. He developed an interest in addiction medicine during his intern year. He has practiced hospital medicine since 2018. He has participated in REMS course training and is buprenorphine waivered. He routinely works with hospitalized patients with substance use disorders to safely bridge them to outpatient treatment. He currently holds academic faculty positions with the Carle Foundation Hospital internal medicine residency and Carle Illinois College of Medicine. He is a member of ASAM, ISAM, and ACP. His interests outside medicine include video games, cooking, fitness, and his family (including his 3 kitties).

    Jeffery Johnson

    DO

    Dr. Johnson is the Medical Director of Behavioral Health Services of Central DuPage Hospital/Northwestern Medicine, Winfield, IL., and a member of the ISAM board. He has practiced Addiction Medicine for over 20 years and was in the first classes certified for both the ASAM and ABAM certifications.

     He was in the first class of physicians trained and wavered to prescribe Buprenorphine. He is actively training Nurses and Physicians in treatment of inpatient and outpatient Substance Use Disorders. He is an investigator on new applications of drugs for Alcohol and Opioid Use disorders. He has served on the Board of Health Chicago HMO and in leadership of Church and Community organizations.

    Elise Wessol (Moderator)

    MD

    Elise Wessol is an addiction medicine physician practicing at Carle Addiction Recovery Center in Champaign, Illinois. She is board certified in family medicine and completed a family medicine residency at Carle Foundation Hospital in Champaign. She is fellowship trained in addiction medicine and graduated from the University of Wisconsin-Madison addiction medicine fellowship program. She now works in outpatient and inpatient settings providing treatment for people with substance use disorders. She serves as a clinical assistant professor of medicine at the Carle Illinois College of Medicine and provides education for clinicians, residents, and medical students in an effort to banish stigma, inform policy, and promote evidence-based treatment for people who suffer from the disease of addiction.

    Credits and Disclosures


    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this internet live course for a maximum of 3 AMA PRA Category 1 Credits™ for the Pain Management and Opioids: Balancing Risks and Benefits course and 1AMA PRA Category 1 Credits™ for the Sexual Harassment in the Medical World course. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification


    American Board of Preventive Medicine (ABPM)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 4 LLSA credits towards ABPM MOC Part II requirements.

    American Board of Anesthesiology (ABA)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    American Board of Pediatrics (ABP)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 4 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

    American Board of Internal Medicine (ABIM)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credits.

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    American Board of Addiction Medicine (ABAM)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    CME Reviewer and Disclosure Information


    ASAM CME Committee Reviewer

    Catherine Friedman, MD, FAPA, DFASAM – No Relevant Financial Disclosures 

    Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    Faculty and Panelists


    Raymond Bertino, MD – No Relevant Financial Disclosures 
    Peoria, IL

    Patrick Leonberger – No Relevant Financial Disclosures 
    Beaver Dam Community Hospitals, Inc, Sun Prairie, WI

    Jeffrey T. Johnson, DO, FASAM – No Relevant Financial Disclosures 
    Medical Director, BHS of Central Dupage Hospital, Winfield, IL

    Gagandeep Goyal, MD– No Relevant Financial Disclosures
    Addiction Wellness Services, South Barrington, IL

    • Register
      • Non-Member - Free!
      • Regular Member - Free!
      • Retired - Free!
      • Early Career Physician - Free!
      • Resident - Free!
      • Student - Free!
      • Associate - Free!
      • ASAM Staff - Free!
      • International Member - Free!
      • Emeritus Member - Free!
      • Provisional Member - Free!
      • Fellow Member - Free!
      • Honorary Member - Free!
      • CRT Member - Free!
    • More Information
  • The ASAM Alcohol Withdrawal Management Webinar Series - Fundamentals

    Contains 4 Component(s), Includes Credits

    The first of its series, this session outlines the highlights of the ASAM Clinical Practice Guideline on Alcohol Withdrawal Management, and addresses related concerns raised during the current COVID-19 pandemic.

    image


    The ASAM Alcohol Withdrawal Management Webinar Series – Fundamentals 


    This is the first webinar of The ASAM Alcohol Withdrawal Management Webinar Series. Click here to access the full series of 5 webinars, worth a total of 5 CME (1 CME/webinar).

    Alcohol is responsible for a multitude of health conditions, including Alcohol Withdrawal Syndrome (AWS). While frequently presented in specialty addiction treatment settings, patients experiencing or at risk for developing AWS also receive care in hospitals, emergency departments, and primary care settings. The current management of patients with AWS is inconsistent across care settings and evidence-based care is often not provided. The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management was developed to address current practice concerns and provide clear guidance that will lead to more consistent treatment practices in the field.

    The first of its series, this session outlines the highlights of the ASAM Clinical Practice Guideline on Alcohol Withdrawal Management, and addresses related concerns raised during the current COVID-19 pandemic. 


    Session Information

    Date: Wednesday, July 29, 2020

    Time: 1:00 pm ET / 12:00 pm CT/ 10:00 am PT

    Speaker(s): Lewis Nelson, MD

    Learning Objectives

    By completing this session, you will be able to:

    • 1. Summarize the guideline’s treatment recommendations and discuss how they should be used in practice.
    • 2. Address the gaps in the management of alcohol withdrawal.
    • 3. Recognize the unique needs and recommendations during the COVID-19 pandemic.

    Lewis S. Nelson

    MD

    Lewis S. Nelson MD
    Affiliation: Chair, Department of Emergency Medicine
    Rutgers New Jersey Medical School

    Dr. Nelson is Professor and Chair of the Department of Emergency Medicine and Chief of the Division of Medical Toxicology at Rutgers New Jersey Medical School in Newark, NJ. He is a member of the Board of Directors of the American Board of Emergency Medicine and a Past-President of the American College of Medical Toxicology. He remains actively involved with CDC, FDA, DHS, and with several professional medical organizations including ASAM. Dr. Nelson is an editor of the textbook Goldfrank’s Toxicologic Emergencies and on the editorial boards of several journals. In addition to providing direct clinical care to patient in the ED and his efforts at New Jersey Poison Information & Education System, his specific expertise include the consequences of licit and illicit opioids, emerging drugs of abuse, opioid stewardship, and alcohol withdrawal.

    ACCME Accredited with Commendation

    CME/CE Credits

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification (MOC)

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1 LLSA credit towards ABPM MOC Part II requirements.

    ABA Maintenance of Certification (MOC)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    ABP Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 1 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

    ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    ABAM Transitional Maintenance of Certification (Tmoc)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    Program Planning Committee, CME Committee, Medical Education Council (MEC)

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity. 

    ASAM CME Committee Reviewer

    Ed Salsitz, MD, DFASAM - No Financial Disclosures

    Faculty & Planning Committee Disclosures

    Lewis S. Nelson, MD, FASAM (Chair) – No Relevant Financial Disclosures

    Kurt Kleinschmidt, MD, FASAM – No Relevant Financial Disclosures

    Gerald E. Marti, MD, PhD – No Relevant Financial Disclosures

    Darius Rastegar, MD, FASAM – No Relevant Financial Disclosures

    Dazhe Cao, MD – No Relevant Financial Disclosures

    George Kolodner, MD, DLFAPA, FASAM – Does Disclose: Kolmac Outpatient Recovery Centers, Self, Employment, Ownership Interest (includes stock, stock options, patent or other intellectual property) Clinical Condition: Substance Use Disorder

    Michael F. Weaver, MD, DFASAM – No Relevant Financial Disclosures


    • Register
      • Non-Member - Free!
      • Regular Member - Free!
      • Retired - Free!
      • Early Career Physician - Free!
      • Resident - Free!
      • Student - Free!
      • Associate - Free!
      • ASAM Staff - Free!
      • International Member - Free!
      • Emeritus Member - Free!
      • Provisional Member - Free!
      • Fellow Member - Free!
      • Honorary Member - Free!
      • CRT Member - Free!
    • More Information
  • The ASAM Board Exam Study Course - Virtual 2020

    Contains 25 Product(s)

    The Board Exam Study Course is the essential primer for physicians and other healthcare professionals who are preparing for a career in addiction medicine, and for primary care providers who wish to increase their skills in identifying and managing patients whose medical problems are caused or exacerbated by substance use disorders.

    Overview

    The Board Exam Study Course is the essential primer for physicians and other healthcare professionals who are preparing for a career in addiction medicine, and for primary care providers who wish to increase their skills in identifying and managing patients whose medical problems are caused or exacerbated by substance use disorders.

    Learning Objectives

    Upon completion attendees will be able to:

    • Demonstrate practical knowledge on the neurobiology of addiction and articulate its activity in terms useful in a clinical setting
    • Describe the effects of alcohol, tobacco and other drugs in both tolerant and non-tolerant individuals
    • Describe the process for diagnosing addiction and differentiating the symptoms of addiction from those of other medical or psychiatric disorders
    • Explain the various pharmacologic and psychosocial treatments for addictive disorders and describe the factors that should be considered in selecting a treatment modality to match the needs of a specific patient
    • Describe the precipitants of relapse and current evidence-based practices to prevent and manage relapse
    ACCME Accredited with Commendation

    CME/CE Credits

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this live and enduring activity for a maximum of 18.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    American Academy of Family Physicians (AAFP) Credits

    This Blended Learning activity, Virtual Board Exam Study Course, has been reviewed by the American Academy of Family Physicians and has a term of 07/16/2020 - 07/16/2021. This activity is acceptable for up to 18.50 Prescribed credit(s); the total amount of credit consists of 12.50 Live Prescribed credits and 6.00 Enduring Prescribed credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    AMA / AAFP Equivalency

    AAFP Prescribed credit is accepted by the American Medical Association as equivalent to AMA PRA Category 1 Credits™ toward the AMA Physician’s Recognition Award. When applying for the AMA PRA, Prescribed credit earned must be reported as Prescribed, not as Category 1.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification (MOC)

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 18.5 LLSA credit towards ABPM MOC Part II requirements.

    ABA Maintenance of Certification (MOC)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    ABP Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 18.5 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

     ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 18.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    ABAM Transitional Maintenance of Certification (Tmoc)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity. View disclosure listing here.

    • Register
      • Non-Member - $599
      • Regular Member - $449
      • Retired - $449
      • Early Career Physician - $449
      • Resident - $299
      • Student - $299
      • Associate - $299
      • ASAM Staff - Free!
      • International Member - $449
      • Emeritus Member - $449
      • Provisional Member - $449
      • Fellow Member - $449
      • Honorary Member - $449
      • CRT Member - $449
    • More Information
  • Treatment of Opioid Use Disorder: Waiver Qualifying - Washington, DC - Saturday, August 22, 2020

    Contains 3 Component(s), Includes Credits

    The ASAM Treatment of Opioid Use Disorder Course covers all medications and treatments for opioid use disorder and provides the required education needed to obtain the waiver to prescribe buprenorphine.

    image

    Saturday, August 22, 2020 | 8:00 am - 5:30 pm ET

    Live Virtual Course


    Overview

    Welcome to the ASAM Treatment of Opioid Use Disorder Course. This course covers all medications and treatments for opioid use disorder, and provides the required education needed to obtain the waiver to prescribe buprenorphine. ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. 

    Getting Started

    Please log in to begin. If you do not know your password, or you have forgotten it, select "Forgot Password" and you will be emailed a link to reset your password. Once you have completed the live course, return here to claim CME for the course. If you have any questions, please contact education@ASAM.org.

    Learning Objectives 

    At the end of the course, you will be able to:

    1. Assess and diagnose patients with opioid use disorder while considering severity, chronicity, individual characteristics, and psychiatric and medical comorbidities.

    2. Develop an individualized, patient-centered treatment plan by evaluating appropriate medication and psychosocial intervention options.

    3. Monitor progress and modify treatment plan based on patient needs and treatment goals.

    4. Implement best practices for office systems to support treatment with medication for opioid use disorder.

    5. Examine misconceptions, stigma, and complexities (bioethical, social, clinical, public health) associated with the use of medications to treat opioid use disorder.

    Overall

    Apply for a waiver to prescribe buprenorphine to patients with opioid use disorder.

    Accreditation & Disclosures

    Date of Release: July 2015
    Approved Through: July 2023

    ACCME Accredited with Commendation

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this live activity for a maximum of 8 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    ABAM Transitional Maintenance of Certification (tMOC)

    This course has been designated as an approved CME Activity by the American Board of Addiction Medicine (ABAM). Physicians enrolled in the ABAM Maintenance of Certification (MOC) Program can apply a maximum of 8 AMA PRA Category 1 Credit(s)™ to the CME requirement for Part II: Lifelong Learning and Self-Assessment.

    Disclosures

    In accordance with the disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all educational activities. These policies include resolving all conflicts of interest between the CME Committee, Planning Committee and faculty, and commercial interests that might otherwise compromise the goal and educational integrity of this activity. All CME Committee, Planning Committee and faculty participating in the activity have disclosed all relevant financial relationships with commercial interests. The CME Committee has reviewed these disclosures and determined that the planning committee and faculty relationships are not inappropriate in the content of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    ASAM Treatment of Opioid Use Disorder Course Program Planning Committee

    NameNature of Relevant Financial Relationship
    Dan Alford, MD, MPH, DFASAM, ChairNone
    Edwin Salsitz, MD, DFASAM, Curriculum DirectorNone
    Alta DeRoo, MD, FASAM, FACOGNone
    Soraya Azari, MDNone
    Jill Mattingly, DHSc, MMSc, PA-CNone
    Debra Newman, PA-C, MPAS, MPHCommercial Interest: AbbVie
    What was received: Honoraria
    Role: Expert faculty for CME activities
    Commercial Interest: Gilead
    What was received: Honoraria
    Role: Expert faculty for CME activities
    Mary McMasters, MD, DFASAMNone
    Yngvild K. Olsen, MD, MPH, DFASAMNone
    Shawn Ryan, MD, MBA, FASAMCommercial Interest: Crosswave 
    What was received: Stock 
    Role: Advisor
    Commercial Interest: Dynamicare
    What was received: Stock
    Role: Advisor
    Kristin Smith, DNP, FNP-C, AAHIVSNone
    Tricia E. Wright, MD, MS, FACOG, DFASAMNone

    ASAM CME Committee

    NameNature of Relevant Financial Relationship
    Catherine Friedman, MD, FAPA, DFASAM, ChairNone
    Catharina Armstrong, MD, MPHNone
    Subhadeep Barman, MD, FASAM, FAPANone
    Benjamin Bearnot, MD, MPH, FASAMCommercial Interest: Johnson and Johnson
    What was received: Common stock
    Role: None
    Commercial Interest: Baxter International
    What was received: Common stock
    Role: None
    Commercial Interest: Takeda Pharmaceuticals
    What was received: Common stock
    Role: none
    R. Jeffrey Goldsmith, MD, DLFAPA, DFASAMCommercial Interest: Alkermes
    What was received: Travel expenses
    Role: Speaker
    Zwaantje H. Hamming, FNP-C, CARN-APNone
    Herbert L. Malinoff, MD, FACP, DFASAM None
    Noel Ilogu, MD, MRCP, DFASAMNone
    Edwin A. Salsitz, MD, DFASAMNone
     ASAM Staff and Consultants
    Arlene C. Deverman, MA, CAE, CFRENone
    Sandy MetcalfeNone
    Kate M. BrundageNone

    ASAM Medical Education Council

    NameNature of Relevant Financial Relationship
    Peter Selby, MBBS, CCFP, FCFP, MHSc, DFASAM, ChairCommercial Interest: Johnson & Johnson; Novartis; Pfizer Inc.
    What was received: Received free/discounted materials for research studies through an open tender process
    Role: Research Studies
    Commercial Interest: Pfizer Inc. Global Research Awards for Nicotine Dependence (GRAND).
    What was received: Grant funds
    Role: Principal investigator on research study
    Commercial Interest: Johnson & Johnson E-NRT Advisory Board
    What was received: Consulting Fees
    Role: Consulting on Johnson & Johnson E-NRT Advisory Board
    Daniel P. Alford, MD, MPH, DFASAMNone
    Michael Fingerhood, MD, FACP, FASAMNone
    Catherine R. Friedman, MD, FAPA, DFASAMNone
    Adam J. Gordon, MD, MPH, FACP, DFASAMNone
    Miriam S. Komaromy, MD, FACP, DFASAMNone
    Edwin A. Salsitz, MD, DFASAMNone
    Brian Hurley, MD, MBA, DFASAMNone
    Mark A. Weiner, MD, FASAMNone
     ASAM Staff and ConsultantsNone
    Penny S. Mills, MBANone
    Arlene C. Deverman, MA, CAE, CFRENone
    Marcia Jackson, PhDNone
    Dawn C. PiotrowskiNone
    Molly S. MazukNone
    Alexandra (Alli) KrouseNone
    Jennifer L. ButchartCommercial Interest: Merck
    What was received: Spouse received stocks
    Role: Stockholder


    Target Audience

    1. Physicians, Nurse Practitioners, Clinical Nurse Specialists, and Physician Assistants who wish to obtain a waiver to prescribe buprenorphine in office-based treatment of opioid use disorder.
    2. Clinicians and healthcare team members working with physicians who prescribe buprenorphine in office-based treatment of opioid use disorder.

    How to Claim CME

    1. Fill out the survey by clicking the “Fill out Survey” button in the box titled “Complete Live Portion Evaluation” at the end of the training.
      Pro tip: Be sure to scroll down on all Likert Scale questions. There are answers that expand past the size of the survey window.
    2. Submit the evaluation. (The next box should activate and the evaluation box should turn green with a white check mark)
    3. Click the button “Claim Medical Credits” in the box titled “CME Certificate”
    4. Choose the type of credit (Physician or Non-physician) and click submit.
    5. Click the button “View/Print Certificate” to save or print your certificate
      Pro tip: If you ever lose your certificate, you can come back to the e-Learning Center and view it on your Transcript (found on Dashboard)

    How to Apply for a Waiver

    Physicians

    SAMHSA reviews waiver applications within 45 business days of receipt. If approved, you will receive a letter via email that confirms your waiver and includes your prescribing identification number.

    Waiver applications are forwarded to the DEA. DEA regulations require your prescribing identification number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with your regular DEA number.

    If you have not received confirmation of receipt of your application, or if it has been more than 45 business days since submitting it, contact CSAT by email: infobuprenorphine@samhsa.hhs.gov or call 866.287.2728.

    Other Approved Prescribers

    Apply

    NPs and PAs who have completed the 24 hours of required training may seek to obtain a DATA 2000 waiver for up to 30 patients by completing the Waiver Notification Form. Effective February 27, 2017, SAMHSA will only accept electronic submissions of the NOI.

    NPs and PAs may send copies of their training certificates to infobuprenorphine@samhsa.hhs.govor fax them to 301.576.5237. These waiver applications are forwarded to the Drug Enforcement Administration (DEA), which will assign the NP or PA a special identification number. DEA regulations require this number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with the NP’s or PA’s regular DEA registration number.

    SAMHSA shall review waiver applications within 45 days of receipt. If approved, NPs and PAs will receive a letter via email that confirms their waiver and includes their prescribing identification number. 

    Qualify

    To qualify for a waiver to treat patients with Opioid Use Disorder, NPs and PAs must:

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain
    • Complete no less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD
    • If required by state law, supervision or working in collaboration with a qualifying physician to prescribe medications for the treatment of OUD may be required.

    Please ensure that your state regulations allow you to prescribe buprenorphine and other medications to treat OUD before you apply for the waiver.  Some states may have overriding state legislation that will prevent NPs from prescribing these medications even if Federal law allows it.

    Overview of Legislation

    Physicians

    The Drug Abuse Treatment Act of 2000 (DATA 2000) specifies training is necessary for physicians to obtain a waiver to engage in office‐based treatment of opioid use disorders using drugs approved by the FDA on Schedules III, IV, and V. This course addresses those requirements using a curriculum approved by CSAT/SAMHSA and ASAM, who is one of the national organizations named in the DATA 2000 legislation as eligible to prepare and administer these courses.

    Nurse Practitioners & Physician Assistants

    On July 22, 2016, President Obama signed the Comprehensive Addiction and Recovery Act (CARA) into law. CARA authorizes qualified NPs and PAs to become waivered to prescribe buprenorphine in office-based settings for patients with Opioid Use Disorder (OUD) for a five-year period expiring in October 2021.    

    To qualify, NPs and PAs must: 

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain  
    • Complete not less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD  
    • If required by state law, be supervised or work in collaboration with a qualifying physician to prescribe medications for the treatment of OUD

    HHS' announcement on November 16, 2016, enables NPs and PAs to immediately begin taking the 24 hours of required training. For the full HHS announcement, click here.

    NPs and PAs can begin the training immediately by taking the 8-hour buprenorphine course ASAM currently offers or that other stakeholders offer (see below for more information). The remaining 16 hours will have to be completed with one training provider. ASAM is developing multiple 16-hour training course options and formats, including collaborations with:

    The ASAM Treatment of Opioid Use Disorder Course has been made available in part by an unrestricted educational grant from Indivior, Inc.

    • Register
      • Non-Member - Free!
      • Regular Member - Free!
      • Retired - Free!
      • Early Career Physician - Free!
      • Resident - Free!
      • Student - Free!
      • Associate - Free!
      • ASAM Staff - Free!
      • International Member - Free!
      • Emeritus Member - Free!
      • Provisional Member - Free!
      • Fellow Member - Free!
      • Honorary Member - Free!
      • CRT Member - Free!
    • More Information
  • The ASAM National Practice Guideline 2020 Focused Update Webinar – OUD and Pain

    Contains 4 Component(s), Includes Credits

    This session will provide an overview of the new and updated recommendations and in-depth information on treating pain in individuals with Opioid Use Disorder from the ASAM National Practice Guideline.

    image

    The ASAM National Practice Guideline 2020 Focused Update Webinar – OUD and Pain


    This webinar follows the ASAM National Practice Guideline 2020 Focused Update Fundamentals webinar, which outlines the new and updated recommendations in the 2020 Focused Update of the National Practice Guideline for the Treatment of Opioid Use Disorder

    Acute and chronic pain is common in opioid use disorder. Pain is an important factor in non-adherence to treatment in Opioid Use Disorder (OUD). In the context of the current epidemic of nonmedical prescription drug use, knowledge of safe and effective pain management is critical for the practitioner. This webinar will provide an overview of the new and updated recommendations and in-depth information on treating pain in individuals with OUD from the ASAM National Practice Guideline.

    Session Information 

    Date: Tuesday, July 21, 2020

    Time: 1:00 pm ET / 12:00 pm CT/ 10:00 am PT

    Speaker(s): Timothy Wiegand, MD, FACMT, FAACT, FASAM

    Learning Objectives 

    By completing this webinar, you will be able to:

    1. Summarize the guideline’s treatment recommendations for individuals with pain & OUD & how they should be used in practice.
    2. Identify the fundamental components of an OUD patient assessment and diagnosis for individuals with pain.
    3. Recognize the unique needs and treatment recommendations for individuals with pain

    Timothy J. Wiegand

    MD, FACMT, FAACT, FASAM

    Tim Wiegand MD, DABAM, FACMT, FAACT was trained in internal medicine and completed fellowship training in Medical Toxicology at the University of California, San Francisco in 2006. He was the Medical Director of the Rochester Poison Center until 2010. Dr. Wiegand has been successful in developing a full time, bedside, medical toxicology consultation service and is very active in the practice of Addiction Medicine, having successfully completed his board certification recently. 

    In addition to his primary appointment as Associate Professor of Emergency Medicine at the University of Rochester School of Medicine & Dentistry in Rochester, NY, Dr. Wiegand serves as Medical Director for Huther Doyle Chemical Dependency Treatment Program in Rochester, NY and as a detoxification specialist for Syracuse Behavioral Health in Rochester, NY. 

    Dr. Wiegand serves on the New York Society of Addiction Medicine (NYSAM) Board of Directors as the Communication Committee Chair and he was recently elected to the American College of Medical Toxicology Board of Directors to begin a 3 year term in October, 2015. He currently serves as the chair of the Addiction Medicine Section for the American College of Medical Toxicology and he recently organized a very successful Addiction Medicine Academy for ACMT prior to their main Annual Scientific Meeting in Clearwater, Florida in March, 2015. Dr. Wiegand has presented for the ASAM Review Course on Pharmacology & Toxicology, MRO and drug testing principles at previous Review Course conferences.

    ACCME Accredited with Commendation

    CME/CE Credits

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this live internet-based activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification (MOC)

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1 LLSA credit towards ABPM MOC Part II requirements.

    ABA Maintenance of Certification (MOC)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    ABP Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 1 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

     ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    ABAM Transitional Maintenance of Certification (Tmoc)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    Program Planning Committee, CME Committee, Medical Education Council (MEC)

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity. 

    ASAM CME Committee Reviewer

    Subhadeep Barman, MD, FASAM, FAPA - No Financial Disclosures

    Faculty & Planning Committee Disclosures

    Kyle M. Kampman, MD – Does Disclose: World Meds (Clinical Condition: Opioid Use Disorder): Consultant/Advisory Board 

    Marc Fishman, MD – Does Disclose: Alkermes (Clinical Condition: OUD): Consultant/Advisory Board, Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received

    Tricia Wright, MD, MS, DFASAM – Does Disclose McKesson (Clinical Condition: Opioid use in pregnancy): Consultant/Advisory Board

    Sandra Springer, MD – Does Disclose: Alkermes Inc (Clinical Condition: Substance Use Disorder) Consultant/Advisory/Board, reviewed research grants for young investigators Clinical Care Options INc (Clinical Condition: Infectious disease) Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)

    George Woody, MD – Does Disclose: Alkermes Inc (Clinical Condition: Opioid Use Disorder) Consultant/Advisory/Board, Consultant/Advisory Board, Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) Indivior (Clinical Condition: opioid use disorders) Consultant/Advisory Board, Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) World Meds (Clinical Condition: Opioid Use Disorders) Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support)

    Daniel Langleben, MD – Does Disclose: Alkermes Inc (Clinical Condition: Opioid Use Disorder) Consultant/Advisory Board 

    Stephen A. Wyatt, DO, FAOAAM, FASAM (Chair) – No Financial Disclosure

    Timothy Wiegand, MD, FACMT, FAACT, DFASAM – No financial Disclosures


    • Register
      • Non-Member - $39
      • Regular Member - Free!
      • Retired - Free!
      • Early Career Physician - Free!
      • Resident - Free!
      • Student - Free!
      • Associate - Free!
      • ASAM Staff - Free!
      • International Member - Free!
      • Emeritus Member - Free!
      • Provisional Member - Free!
      • Fellow Member - Free!
      • Honorary Member - Free!
      • CRT Member - Free!
    • More Information
  • Treatment of Opioid Use Disorder: Waiver Qualifying - Williamsport, PA - Friday, September 4, 2020

    Contains 4 Component(s), Includes Credits

    The ASAM Treatment of Opioid Use Disorder Course covers all medications and treatments for opioid use disorder, and provides the required education needed to obtain the waiver to prescribe buprenorphine.

    image

    Host: Penn College

    Friday, September 4, 2020 | 8:00 am - 5:00 pm ET

    Live Virtual Course

    Register here to attend the live virtual course: 

    https://us02web.zoom.us/webinar/register/WN_5X4HiYrSSKW6gfaCwOJcIw

    Overview

    Welcome to the ASAM Treatment of Opioid Use Disorder Course. This course covers all medications and treatments for opioid use disorder, and provides the required education needed to obtain the waiver to prescribe buprenorphine. ASAM is an approved provider by CSAT/SAMHSA of DATA 2000 training. 

    Getting Started

    Please log in to begin. If you do not know your password, or you have forgotten it, select "Forgot Password" and you will be emailed a link to reset your password. Once you have completed the live course, return here to claim CME for the course. If you have any questions, please contact education@ASAM.org.

    Learning Objectives 

    Module 1 

    1. Assess patients for the full spectrum of harmful opioid use including misuse and use disorders
    2. Describe the current epidemiologic trends in opioid misuse including overdose and use disorders
    3. Recall opioid use neurobiology as it applies to the development of an opioid use disorder and relapse risk
    4. Summarize the laws regulating office-based opioid treatment including the Drug Addiction Treatment Act of 2000 and the Comprehensive Addiction and Recovery Act of 2016
    5. Summarize the clinical pharmacology, efficacy and safety of methadone, buprenorphine and naltrexone in treating opioid use disorders

    Module 2

    1. Identify and assess patients who are appropriate for treatment with medications for an opioid use disorder in an office-based setting
    2. Describe procedures for setting up office systems to support medication prescribing for opioid use disorders
    3. Describe procedures for initiating, stabilizing, maintaining, monitoring and modifying treatment of patients on buprenorphine or naltrexone

    Module 3

    1. Summarize the assessment and management of patients with psychiatric and medical co-morbidities associated with opioid use disorders
    2. Describe unique issues of treating adolescents, young adults, pregnant and postpartum patients maintained on medications for opioid use disorders
    3. Summarize acute and chronic pain management strategies for patients with an opioid use disorder

    Overall

    Apply for a waiver to prescribe buprenorphine to patients with opioid use disorder

    Target Audience

    1. Physicians, Nurse Practitioners, Physician Assistants, Certified Nurse Midwives, Certified Registered Nurse Anesthetists, and Clinical Nurse Specialists who wish to obtain a waiver to prescribe buprenorphine in an office-based setting for opioid use disorder.
    2. Clinicians and healthcare team members working with physicians who prescribe buprenorphine in office-based treatment of opioid use disorder.

    Daniel A. Nauts, MD, FASAM

    Daniel A. Nauts, MD, FASAM

    Dr. Nauts, MD, FASAM completed his undergraduate and medical education at the University of Michigan and joined an internal medicine group practice in Bellingham, Washington.  He left general internal medicine to develop his Addiction Medicine practice; since that time, he has been instrumental in the creation of 3 inpatient programs for those suffering with substance use and co-occurring disorders, outpatient SUD programs, and medication assisted treatment services. 

    Dr. Nauts is an independent contractor for the Montana Primary Care Association providing MAT waiver trainings and technical assistance, community forums on opioid use disorders, academic detailing activities for MAT providers, and helping in strategies to taper patients off high dose morphine equivalents.  Not only is he committed to integrating addiction medicine into primary care but also in promoting the development of more addiction medicine specialists in Montana.

    He is active in the American Society of Addiction Medicine (ASAM), delivers a myriad of presentations for any professional or public audience, has participated in addressing physician and nurse health issues through Professional Assistance Programs, and has provided Addiction Medicine experiences for residents of the Western Montana Family Practice Program and PA students from the University of Washington Medex Program.

    He is a member of the Drug Utilization Board of Mountain Pacific Quality Health providing oversight to the Medicaid formulary, is recognized as a Fellow of the American Society of Addiction Medicine (FASAM), and is certified in the subspecialty of Addiction Medicine by the American Board of Preventive Medicine.  He is the treasurer for the Northwest Society of Addiction Medicine, a Chapter of American Society of Addiction Medicine (ASAM) representing Montana, North Dakota, and Wyoming and is a faculty member of ASAM to provide Data 2000 MAT waiver trainings and The Fundamentals of Addiction Medicine.

    Dr. Nauts is the 2019 recipient of the Award of Merit presented by the Montana Medical Association honoring the work he has done to improve healthcare in Montana. 

    Frank Del Real, MD, FASAM

    Dr. Frank Del Real is the Medical Director at Central Wyoming Counseling Center and Clinical Adjunct Professor and Visiting Attending at the University of Wyoming Family Practice Program. Previously, he was the Medical Director at Wyoming Recovery. Dr. Del Real attended medical school at the University of California, San Diego where he received his M.D. degree. He then completed his residency in Psychiatry at Harbor, UCLA Medical Center. He has practiced as a psychiatrist for 31 years. In addition to his extensive experience in psychiatry he is also Board Certified in addiction medicine. He is one of a few physicians in Wyoming that provides out-patient based opioid treatment for those suffering from opioid use disorders. He is an active member of the American Society of Addiction Medicine (ASAM) where he serves as chairman of the membership committee of the Northwest chapter. He is the immediate past-president of the Northwest Chapter. He was also a member of the ASAM Marijuana Task Force that contributed to the development of the Marijuana Position Paper for ASAM.

    ACCME Accredited with Commendation

    CME/CE Credits

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this live internet-based activity for a maximum of 8 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification (MOC)

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 8 LLSA credit towards ABPM MOC Part II requirements.

    ABA Maintenance of Certification (MOC)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    ABP Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 8 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

     ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 8 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    ABAM Transitional Maintenance of Certification (Tmoc)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    ASAM Treatment of Opioid Use Disorder Course Program Planning Committee

    NameNature of Relevant Financial Relationship
    Dan Alford, MD, MPH, DFASAM, ChairNone
    Edwin Salsitz, MD, DFASAM, Curriculum DirectorNone
    Alta DeRoo, MD, FASAM, FACOGNone
    Soraya Azari, MDNone
    Jill Mattingly, DHSc, MMSc, PA-CNone
    Debra Newman, PA-C, MPAS, MPHCommercial Interest: AbbVie
    What was received: Honoraria
    Role: Expert faculty for CME activities
    Commercial Interest: Gilead
    What was received: Honoraria
    Role: Expert faculty for CME activities
    Mary McMasters, MD, DFASAMNone
    Yngvild K. Olsen, MD, MPH, DFASAMNone
    Shawn Ryan, MD, MBA, FASAMCommercial Interest: Crosswave 
    What was received: Stock 
    Role: Advisor
    Commercial Interest: Dynamicare
    What was received: Stock
    Role: Advisor
    Kristin Smith, DNP, FNP-C, AAHIVSNone
    Tricia E. Wright, MD, MS, FACOG, DFASAMNone

    ASAM CME Committee

    NameNature of Relevant Financial Relationship
    Catherine Friedman, MD, FAPA, DFASAM, ChairNone
    Catharina Armstrong, MD, MPHNone
    Subhadeep Barman, MD, FASAM, FAPANone
    Benjamin Bearnot, MD, MPH, FASAMCommercial Interest: Johnson and Johnson
    What was received: Common stock
    Role: None
    Commercial Interest: Baxter International
    What was received: Common stock
    Role: None
    Commercial Interest: Takeda Pharmaceuticals
    What was received: Common stock
    Role: none
    R. Jeffrey Goldsmith, MD, DLFAPA, DFASAMCommercial Interest: Alkermes
    What was received: Travel expenses
    Role: Speaker
    Zwaantje H. Hamming, FNP-C, CARN-APNone
    Herbert L. Malinoff, MD, FACP, DFASAM None
    Noel Ilogu, MD, MRCP, DFASAMNone
    Edwin A. Salsitz, MD, DFASAMNone
     ASAM Staff and Consultants
    Arlene C. Deverman, MA, CAE, CFRENone
    Sandy MetcalfeNone
    Kate M. BrundageNone

    ASAM Medical Education Council

    NameNature of Relevant Financial Relationship
    Peter Selby, MBBS, CCFP, FCFP, MHSc, DFASAM, ChairCommercial Interest: Johnson & Johnson; Novartis; Pfizer Inc.
    What was received: Received free/discounted materials for research studies through an open tender process
    Role: Research Studies
    Commercial Interest: Pfizer Inc. Global Research Awards for Nicotine Dependence (GRAND).
    What was received: Grant funds
    Role: Principal investigator on research study
    Commercial Interest: Johnson & Johnson E-NRT Advisory Board
    What was received: Consulting Fees
    Role: Consulting on Johnson & Johnson E-NRT Advisory Board
    Daniel P. Alford, MD, MPH, DFASAMNone
    Michael Fingerhood, MD, FACP, FASAMNone
    Catherine R. Friedman, MD, FAPA, DFASAMNone
    Adam J. Gordon, MD, MPH, FACP, DFASAMNone
    Miriam S. Komaromy, MD, FACP, DFASAMNone
    Edwin A. Salsitz, MD, DFASAMNone
    Brian Hurley, MD, MBA, DFASAMNone
    Mark A. Weiner, MD, FASAMNone
     ASAM Staff and ConsultantsNone
    Penny S. Mills, MBANone
    Arlene C. Deverman, MA, CAE, CFRENone
    Marcia Jackson, PhDNone
    Dawn C. PiotrowskiNone
    Molly S. MazukNone
    Alexandra (Alli) KrouseNone
    Jennifer L. ButchartCommercial Interest: Merck
    What was received: Spouse received stocks
    Role: Stockholder


    How to Claim CME

    1. Fill out the survey by clicking the “Fill out Survey” button in the box titled “Complete Live Portion Evaluation” at the end of the training.
      Pro tip: Be sure to scroll down on all Likert Scale questions. There are answers that expand past the size of the survey window.
    2. Submit the evaluation. (The next box should activate and the evaluation box should turn green with a white check mark)
    3. Click the button “Claim Medical Credits” in the box titled “CME Certificate”
    4. Choose the type of credit (Physician or Non-physician) and click submit.
    5. Click the button “View/Print Certificate” to save or print your certificate
      Pro tip: If you ever lose your certificate, you can come back to the e-Learning Center and view it on your Transcript (found on Dashboard)

    How to Apply for a Waiver

    Physicians

    SAMHSA reviews waiver applications within 45 business days of receipt. If approved, you will receive a letter via email that confirms your waiver and includes your prescribing identification number.

    Waiver applications are forwarded to the DEA. DEA regulations require your prescribing identification number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with your regular DEA number.

    If you have not received confirmation of receipt of your application, or if it has been more than 45 business days since submitting it, contact CSAT by email: infobuprenorphine@samhsa.hhs.gov or call 866.287.2728.

    Other Approved Prescribers

    Apply

    NPs and PAs who have completed the 24 hours of required training may seek to obtain a DATA 2000 waiver for up to 30 patients by completing the Waiver Notification Form. Effective February 27, 2017, SAMHSA will only accept electronic submissions of the NOI.

    NPs and PAs may send copies of their training certificates to csatbupinfo@dsgonline.com. These waiver applications are forwarded to the Drug Enforcement Administration (DEA), which will assign the NP or PA a special identification number. DEA regulations require this number to be included on all buprenorphine prescriptions for opioid dependency treatment, along with the NP’s or PA’s regular DEA registration number.

    SAMHSA shall review waiver applications within 45 days of receipt. If approved, NPs and PAs will receive a letter via email that confirms their waiver and includes their prescribing identification number. 

    Qualify

    To qualify for a waiver to treat patients with Opioid Use Disorder, NPs and PAs must:

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain
    • Complete no less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD
    • If required by state law, supervision or working in collaboration with a qualifying physician to prescribe medications for the treatment of OUD may be required.

    Please ensure that your state regulations allow you to prescribe buprenorphine and other medications to treat OUD before you apply for the waiver.  Some states may have overriding state legislation that will prevent NPs from prescribing these medications even if Federal law allows it.

    Overview of Legislation

    Physicians

    The Drug Abuse Treatment Act of 2000 (DATA 2000) specifies training is necessary for physicians to obtain a waiver to engage in office‐based treatment of opioid use disorders using drugs approved by the FDA on Schedules III, IV, and V. This course addresses those requirements using a curriculum approved by CSAT/SAMHSA and ASAM, who is one of the national organizations named in the DATA 2000 legislation as eligible to prepare and administer these courses.

    Nurse Practitioners & Physician Assistants

    On July 22, 2016, President Obama signed the Comprehensive Addiction and Recovery Act (CARA) into law. CARA authorizes qualified NPs and PAs to become waivered to prescribe buprenorphine in office-based settings for patients with Opioid Use Disorder (OUD) for a five-year period expiring in October 2021.    

    To qualify, NPs and PAs must: 

    • Be licensed under state law to prescribe schedule III, IV, or V medications for pain  
    • Complete not less than 24 hours of appropriate education through a qualified provider
    • Through other training or experience, demonstrate the ability to treat and manage OUD  
    • If required by state law, be supervised or work in collaboration with a qualifying physician to prescribe medications for the treatment of OUD

    HHS' announcement on November 16, 2016, enables NPs and PAs to immediately begin taking the 24 hours of required training. For the full HHS announcement, click here.

    NPs and PAs can begin the training immediately by taking the 8-hour buprenorphine course ASAM currently offers or that other stakeholders offer (see below for more information). The remaining 16 hours will have to be completed with one training provider. ASAM is developing multiple 16-hour training course options and formats, including collaborations with:

    The ASAM Treatment of Opioid Use Disorder Course has been made available in part by an unrestricted educational grant from Indivior, Inc.

    • Register
      • Non-Member - Free!
      • Regular Member - Free!
      • Retired - Free!
      • Early Career Physician - Free!
      • Resident - Free!
      • Student - Free!
      • Associate - Free!
      • ASAM Staff - Free!
      • International Member - Free!
      • Emeritus Member - Free!
      • Provisional Member - Free!
      • Fellow Member - Free!
      • Honorary Member - Free!
      • CRT Member - Free!
    • More Information
  • Opioid and Amphetamine Treatment Trends Among American Indians in the Great Plains (1 CME)

    Contains 4 Component(s), Includes Credits

    Earn 1 AMA PRA Category 1 Credit(s)™ while learning about opioid and amphetamine treatment trends among American Indians in the Great Plains.

    Earn 1 AMA PRA Category 1 Credit(s)™ while learning about opioid and amphetamine treatment trends among American Indians in the Great Plains. Julian A. Mitton, MD, MPH, Sean Jackson, BS, J. Janet Ho, MD, MPH, and Matthew Tobey, MD, MPH

    Learning objectives: 

    1. Identify traditionally underserved populations who are disproportionately impacted by the opioid and amphetamine epidemic in the United States.

    2. Describe recent trends in the in opioid and amphetamine treatment admissions for American Indians/Alaskan Natives living in the Great Plains relative to that of the general population.

    3. Determine what resources are needed to provide adequate treatment to AI/AN communities.



    ACCME Accredited with Commendation

    CME/CE Credits

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification (MOC)

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1 LLSA credit towards ABPM MOC Part II requirements.

    ABA Maintenance of Certification (MOC)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    ABP Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 1 MOC point in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

     ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    ABAM Transitional Maintenance of Certification (Tmoc)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity authors have disclosed relevant financial relationship information and it is determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    • Register
      • Non-Member - $39
      • Regular Member - Free!
      • Retired - Free!
      • Early Career Physician - Free!
      • Resident - Free!
      • Student - Free!
      • Associate - Free!
      • ASAM Staff - Free!
      • International Member - Free!
      • Emeritus Member - Free!
      • Provisional Member - Free!
      • Fellow Member - Free!
      • Honorary Member - Free!
      • CRT Member - Free!
    • More Information
  • Perceptions of Alcohol Risk among HIV/Hepatitis C Coinfected Patients (1 CME)

    Contains 4 Component(s), Includes Credits

    Earn 1 AMA PRA Category 1 Credit(s)™ while learning about perceptions of alcohol risk among HIV/Hepatitis C coinfected patients.

    Earn 1 AMA PRA Category 1 Credit(s)™ while learning about perceptions of alcohol risk among HIV/Hepatitis C coinfected patients. H. Nina Kim, M.D., Abigail Howell, MPH, Claire E Blevins, PhD, Megan M Pinkston, PhD, Debra S Herman, PhD, Michael D. Stein, M.D.

    Learning objectives: 

    1. Examine how HIV-HCV co-infected patients perceive risk when it comes to using alcohol.

    2. Identify the importance of educating providers about delivering consistent counseling about alcohol avoidance.

    3. Determine new ways of treatment for HIV-HCV co-infected patients.



    ACCME Accredited with Commendation

    CME/CE Credits

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification (MOC)

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1 LLSA credit towards ABPM MOC Part II requirements.

    ABA Maintenance of Certification (MOC)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    ABP Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 1 MOC point in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

     ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    ABAM Transitional Maintenance of Certification (Tmoc)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity authors have disclosed relevant financial relationship information and it is determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    • Register
      • Non-Member - $39
      • Regular Member - Free!
      • Retired - Free!
      • Early Career Physician - Free!
      • Resident - Free!
      • Student - Free!
      • Associate - Free!
      • ASAM Staff - Free!
      • International Member - Free!
      • Emeritus Member - Free!
      • Provisional Member - Free!
      • Fellow Member - Free!
      • Honorary Member - Free!
      • CRT Member - Free!
    • More Information
  • Supporting the Use of Medications for Addiction Treatment in U.S. Drug Courts: Opportunities for Health Professionals (1 CME)

    Product not yet rated Contains 4 Component(s), Includes Credits

    Earn 1 AMA PRA Category 1 Credit(s)™ while learning about opportunities for health professionals to support the use of medications for addiction treatment in U.S. Drug Courts.

    Earn 1 AMA PRA Category 1 Credit(s)™ while learning about opportunities for health professionals to support the use of medications for addiction treatment in U.S. Drug Courts. Nathaniel P Morris, MD, Brandon S Bentzley, MD, PhD

    Learning objectives: 

    1. Define medication assisted treatment (MAT).

    2. Identify stigmas surrounding MAT treatment.

    3. Examine ways in which individual health professionals can support access to MAT in drug courts.

    ACCME Accredited with Commendation

    CME/CE Credits

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification (MOC)

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1 LLSA credit towards ABPM MOC Part II requirements.

    ABA Maintenance of Certification (MOC)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    ABP Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 1 MOC point in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

     ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    ABAM Transitional Maintenance of Certification (Tmoc)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity authors have disclosed relevant financial relationship information and it is determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    • Register
      • Non-Member - $39
      • Regular Member - Free!
      • Retired - Free!
      • Early Career Physician - Free!
      • Resident - Free!
      • Student - Free!
      • Associate - Free!
      • ASAM Staff - Free!
      • International Member - Free!
      • Emeritus Member - Free!
      • Provisional Member - Free!
      • Fellow Member - Free!
      • Honorary Member - Free!
      • CRT Member - Free!
    • More Information
  • The ASAM National Practice Guideline 2020 Focused Update – Pregnant Women

    Contains 4 Component(s), Includes Credits

    This session will provide an overview of the new and updated recommendations and in-depth information on treating pregnant women from the ASAM National Practice Guideline.

    image

    The ASAM National Practice Guideline 2020 Focused Update – Pregnant Women


    This session follows the ASAM National Practice Guideline 2020 Focused Update Fundamentals session, which outlines the new and updated recommendations in the 2020 Focused Update of the National Practice Guideline for the Treatment of Opioid Use Disorder

    Many of the risks associated with opioid use disorder are similar for both pregnant and non-pregnant women. However, opioid use disorder carries additional risks for pregnant women and prenatal risk for the developing fetus. Treatment of pregnant women with MOUD is associated with substantial improvement in outcomes for both mother and child. This session will provide an overview of the new and updated recommendations and in-depth information on treating pregnant women from the ASAM NPG.

    Session Information 

    Date: Tuesday, June 30, 2020

    Time: 2:00 pm ET / 1:00 pm CT/ 11:00 am PT

    Speaker(s): Tricia Wright, MD, MS, FACOG, FASAM

    Learning Objectives 

    By completing this webinar, you will be able to:

    1. Summarize the guideline’s treatment recommendations for the mother-infant dyad and discuss their practical implications. 
    2. Identify the fundamental components of an OUD patient assessment and diagnosis for pregnant and postpartum women.
    3. Recognize the unique needs and treatment recommendations for pregnant and postpartum women.

    Tricia Wright

    MD, MS, FACOG, FASAM

    Tricia Wright, MD, MS recently moved to California from Hawai‘i to become a Professor of Obstetrics, Gynecology and Reproductive Sciences at UCSF. She is board certified in both Obstetrics and Gynecology and Addiction Medicine and a Fellow of the American College of Obstetrics and Gynecology and a Distinguished Fellow of the American Society of Addiction Medicine. She has published multiple papers on pregnancy and addiction as well as a textbook Opioid Use Disorders in Pregnancy published in 2018 by Cambridge University Press. 

    Dr. Wright completed her undergraduate degree in Biological Sciences from Stanford University, her MD from the University of Michigan. She completed her residency in Obstetrics and Gynecology from the University of New Mexico and obtained a Master’s Degree in Clinical Research from the University of Hawai‘i. 

    ACCME Accredited with Commendation

    CME/CE Credits

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this live internet-based activity for a maximum of 1 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification (MOC)

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 1 LLSA credit towards ABPM MOC Part II requirements.

    ABA Maintenance of Certification (MOC)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    ABP Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 1 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

     ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    ABAM Transitional Maintenance of Certification (Tmoc)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    Program Planning Committee, CME Committee, Medical Education Council (MEC)

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity. 

    ASAM CME Committee Reviewer

    Subhadeep Barman, MD, FASAM, FAPA - No Financial Disclosures

    Faculty & Planning Committee Disclosures

    Kyle M. Kampman, MD – Does Disclose: World Meds (Clinical Condition: Opioid Use Disorder): Consultant/Advisory Board 

    Marc Fishman, MD – Does Disclose: Alkermes (Clinical Condition: OUD): Consultant/Advisory Board, Research Grant includes principal investigator, collaborator or consultant and pending grants as well as grants already received

    Tricia Wright, MD, MS, DFASAM – Does Disclose McKesson (Clinical Condition: Opioid use in pregnancy): Consultant/Advisory Board

    Sandra Springer, MD – Does Disclose: Alkermes Inc (Clinical Condition: Substance Use Disorder) Consultant/Advisory/Board, reviewed research grants for young investigators Clinical Care Options INc (Clinical Condition: Infectious disease) Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)

    George Woody, MD – Does Disclose: Alkermes Inc (Clinical Condition: Opioid Use Disorder) Consultant/Advisory/Board, Consultant/Advisory Board, Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) Indivior (Clinical Condition: opioid use disorders) Consultant/Advisory Board, Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support) World Meds (Clinical Condition: Opioid Use Disorders) Other Research Support (includes receipt of drugs, supplies, equipment or other in-kind support)

    Daniel Langleben, MD – Does Disclose: Alkermes Inc (Clinical Condition: Opioid Use Disorder) Consultant/Advisory Board 

    Stephen A. Wyatt, DO, FAOAAM, FASAM (Chair) – No Financial Disclosure

    Timothy Wiegand, MD, FACMT, FAACT, DFASAM – No financial Disclosures


    • Register
      • Non-Member - $39
      • Regular Member - Free!
      • Retired - Free!
      • Early Career Physician - Free!
      • Resident - Free!
      • Student - Free!
      • Associate - Free!
      • ASAM Staff - Free!
      • International Member - Free!
      • Emeritus Member - Free!
      • Provisional Member - Free!
      • Fellow Member - Free!
      • Honorary Member - Free!
      • CRT Member - Free!
    • More Information
  • Supporting Addiction Treatment During COVID-19 (NAM-ASAM Collaboration)

    Contains 3 Product(s)

    This 3-part joint NAM-ASAM series discusses resources and guidance for substance use treatment during the COVID-19 pandemic.

    image


    As the leader in developing clinical guidelines and standards in addiction medicine, ASAM takes its responsibility very seriously. Many providers and programs are urgently working to mitigate risks related to COVID-19. A joint series by the National Academy of Medicine (NAM) and the ASAM provides an overview of increasing COVID-19 resources and discusses evolving guidance to inform your practices during the pandemic. This is a 3 part series:  

    • WEBINAR 1: Helping patients in addiction treatment stay connected during the COVID pandemic- Recorded on May 2nd, 2020 11:00 am ET
    • WEBINAR 2: Challenges for Addiction Treatment across the Continuum of care- Recorded on May 22nd, 2020 2:30 pm ET
    • WEBINAR 3: Coordination across the social safety net to avert a crisis among patients with addiction- June 2, 2020 12:30 pm ET

    ACCME Accredited with Commendation

    CME/CE Credits

    ACCME Accreditation Statement

    The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

    AMA Credit Designation Statement

    The American Society of Addiction Medicine designates this enduring activity for a maximum of 4.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    NAADAC, the Association for Addiction Professionals

    This activity has been approved by the American Society of Addiction Medicine, as a NAADAC Approved Education Provider, for educational credits. NAADAC Provider #295, ASAM is responsible for all aspects of the programming.

    California Association for Drug/Alcohol Educators (CAADE)

    This educational program is approved by CAADE: #CP40 999 1222

    California Association of DUI Treatment Centers (CADTP)

    This educational program is approved by CADTP: #205

    Continuing Education Credits (CEUs)

    Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.

    Maintenance of Certification (MOC)

    ABPM Maintenance of Certification (MOC)

    The American Board of Preventive Medicine (ABPM) has approved this activity for a maximum of 4.5 LLSA credit towards ABPM MOC Part II requirements.

    ABA Maintenance of Certification (MOC)

    This activity contributes to the CME component of the American Board of Anesthesiology’s redesigned Maintenance of Certification in Anesthesiology TM (MOCA®) program, known as MOCA 2.0®.

    ABP Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the activity, with individual assessments of the participant and feedback to the participant, enables the participant to earn a maximum of 4.5 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABP MOC credit.

     ABIM Maintenance of Certification (MOC)

    Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

    ABAM Transitional Maintenance of Certification (Tmoc)

    Successful completion of this activity can be used to satisfy the American Board of Addiction Medicine (ABAM) for Tmoc as credits towards ABAM LLSA Part II requirements.

    American Board of Psychiatry and Neurology (ABPN)

    Successful completion of this CME activity can be used to satisfy the American Board of Psychiatry and Neurology’s (ABPN) CME requirement for Maintenance of Certification program.

    Program Planning Committee, CME Committee, Medical Education Council (MEC), and Faculty Disclosure Information

    In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include resolving all possible conflicts of interest for the Planning Committees, CME Committee, MEC, and Faculty. All activity Planning Committee members and Faculty have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity.

    ACCME’s Policy For Disclosures During The COVID-19 Pandemic

    Per ACCME’s simplified process for COVID-19, the requirement of disclosure of relevant financial relationships and resolution of personal conflicts of interest has been removed. Currently, there are no FDA-approved vaccines or treatments for COVID-19. Hence, there is no possibility of a relevant financial relationship that would create a conflict of interest.

    • Register
      • Non-Member - Free!
      • Regular Member - Free!
      • Retired - Free!
      • Early Career Physician - Free!
      • Resident - Free!
      • Student - Free!
      • Associate - Free!
      • ASAM Staff - Free!
      • International Member - Free!
      • Emeritus Member - Free!
      • Provisional Member - Free!
      • Fellow Member - Free!
      • Honorary Member - Free!
      • CRT Member - Free!
    • More Information